Aidukas personal page - To The Moon

Aidukas

No personal profile

18Follow

2Followers

2Topic

0Badge

2023-02-06

Good

2 AI-Powered Growth Stocks to Buy Right Now

2023-02-18

Good

Reminder: U.S. Market Will Be Closed for Washington's Birthday on Monday, Feb. 20, 2023

2023-08-07

Thieves

Sorry, the original content has been removed

2023-07-26

Good

Sorry, the original content has been removed

2023-05-10

Thieves

Sorry, the original content has been removed

2023-03-02

Oke

2 Stocks Down 55% and 71% to Buy Right Now

2023-02-12

Amazing

The Smartest Investors Are Buying These 3 Beaten-Down Stocks

2023-02-08

Better to 2050!

Sorry, the original content has been removed

2023-02-05

Good

The Stock-Market Rally Survived a Confusing Week. Here's What Comes Next

2023-02-19

Ok

Reminder: U.S. Market Will Be Closed for Washington's Birthday on Monday, Feb. 20, 2023

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4133623950260892","uuid":"4133623950260892","gmtCreate":1670520856575,"gmtModify":1673019533729,"name":"Aidukas","pinyin":"aidukas","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","hatId":"ca_profile_frame_DWr5S1","hatName":"","vip":1,"status":2,"fanSize":2,"headSize":18,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.09.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.20","exceedPercentage":"80.44%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.01.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":3,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":484877028934280,"gmtCreate":1759408768484,"gmtModify":1759408771675,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BABA\">$Alibaba(BABA)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/BABA\">$Alibaba(BABA)$ </a>&nbsp;","text":"$Alibaba(BABA)$","images":[{"img":"https://community-static.tradeup.com/news/9ca6a1ba87b97edecb550ccd21e4867c","width":"986","height":"1963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/484877028934280","isVote":1,"tweetType":1,"viewCount":956,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":483843910361440,"gmtCreate":1759156395144,"gmtModify":1759156397892,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/BABA\">$Alibaba(BABA)$ </a>&nbsp;[Miser]&nbsp;&nbsp;","listText":"<a href=\"https://ttm.financial/S/BABA\">$Alibaba(BABA)$ </a>&nbsp;[Miser]&nbsp;&nbsp;","text":"$Alibaba(BABA)$ [Miser]","images":[{"img":"https://community-static.tradeup.com/news/4f00a6f422d409d6b45559286c05ec8b","width":"986","height":"1963"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/483843910361440","isVote":1,"tweetType":1,"viewCount":1020,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":475347732459880,"gmtCreate":1757078987713,"gmtModify":1757078991531,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Good,keep going!","listText":"Good,keep going!","text":"Good,keep going!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/475347732459880","repostId":"2560514776","repostType":2,"repost":{"id":"2560514776","kind":"news","pubTimestamp":1755656700,"share":"https://ttm.financial/m/news/2560514776?lang=en_US&edition=fundamental","pubTime":"2025-08-20 10:25","market":"hk","language":"zh","title":"Big Bank Ratings | JPMorgan Chase: Maintaining Amazon's \"Best Investment Philosophy\" rating and expanding the same-day delivery service will help increase market share","url":"https://stock-news.laohu8.com/highlight/detail?id=2560514776","media":"格隆汇APP","summary":"摩根大通分析师Anmuth发表报告指，尽管竞争加剧，亚马逊扩展新鲜食品即日送服务，将支持其在美国的网购市场持续增加市占率。该行维持对亚马逊的“最佳投资理念”评级，目标价为265美元。分析师认为，亚马逊的食品杂货攻势或进一步扩大其在美国网购市场的领先优势，并有助提升Prime吸引力、带动消费频率及广告收入，同时迫使传统零售商重新检视定价及配送收费。此外，杂货客户增加，有助推动广告业务。该行预期，随着更多品牌争取在亚马逊平台曝光，其广告收入将进一步上升。\n\n\n海量资讯、精准解读，尽在新浪财经APP","content":"<p><html><body><div><p cms-style=\"font-L\"><a href=\"https://laohu8.com/S/JPM\">JPMorgan Chase</a>Analyst Anmuth issued a report saying that despite intensified competition,<a href=\"https://laohu8.com/S/AMZN\">Amazon</a>Expanding the same-day delivery service of fresh food will support its continued increase in market share in the online shopping market in the United States. The bank maintained its \"best investment idea\" rating on Amazon with a target price of $265.</p><p><p cms-style=\"font-L\">Analysts believe that Amazon's grocery offensive may further expand its leading edge in the U.S. online shopping market, and help enhance Prime's attractiveness, drive consumption frequency and advertising revenue, while forcing traditional retailers to re-examine pricing and delivery charges. In addition, the increase in grocery customers helped drive the advertising business. The bank expects its advertising revenue to rise further as more brands strive for exposure on the Amazon platform.</p><p><div><div><img src=\"\"/></div><div>Massive information and accurate interpretation, all in Sina Finance APP</div></div></div></body></html></p>","source":"sina","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Big Bank Ratings | JPMorgan Chase: Maintaining Amazon's \"Best Investment Philosophy\" rating and expanding the same-day delivery service will help increase market share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBig Bank Ratings | JPMorgan Chase: Maintaining Amazon's \"Best Investment Philosophy\" rating and expanding the same-day delivery service will help increase market share\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">格隆汇APP</strong><span class=\"h-time small\">2025-08-20 10:25</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><body><div><p cms-style=\"font-L\"><a href=\"https://laohu8.com/S/JPM\">JPMorgan Chase</a>Analyst Anmuth issued a report saying that despite intensified competition,<a href=\"https://laohu8.com/S/AMZN\">Amazon</a>Expanding the same-day delivery service of fresh food will support its continued increase in market share in the online shopping market in the United States. The bank maintained its \"best investment idea\" rating on Amazon with a target price of $265.</p><p><p cms-style=\"font-L\">Analysts believe that Amazon's grocery offensive may further expand its leading edge in the U.S. online shopping market, and help enhance Prime's attractiveness, drive consumption frequency and advertising revenue, while forcing traditional retailers to re-examine pricing and delivery charges. In addition, the increase in grocery customers helped drive the advertising business. The bank expects its advertising revenue to rise further as more brands strive for exposure on the Amazon platform.</p><p><div><div><img src=\"\"/></div><div>Massive information and accurate interpretation, all in Sina Finance APP</div></div></div></body></html></p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"https://finance.sina.com.cn/stock/bxjj/2025-08-20/doc-infmqwai1909746.shtml\">格隆汇APP</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-08-20/doc-infmqwai1909746.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","article_id":"2560514776","content_text":"摩根大通分析师Anmuth发表报告指，尽管竞争加剧，亚马逊扩展新鲜食品即日送服务，将支持其在美国的网购市场持续增加市占率。该行维持对亚马逊的“最佳投资理念”评级，目标价为265美元。分析师认为，亚马逊的食品杂货攻势或进一步扩大其在美国网购市场的领先优势，并有助提升Prime吸引力、带动消费频率及广告收入，同时迫使传统零售商重新检视定价及配送收费。此外，杂货客户增加，有助推动广告业务。该行预期，随着更多品牌争取在亚马逊平台曝光，其广告收入将进一步上升。\n\n\n海量资讯、精准解读，尽在新浪财经APP","news_type":1,"symbols_score_info":{"AMZN":1}},"isVote":1,"tweetType":1,"viewCount":1408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":290710401978592,"gmtCreate":1712000163785,"gmtModify":1712000167773,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Company kaput","listText":"Company kaput","text":"Company kaput","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/290710401978592","repostId":"2424074404","repostType":2,"isVote":1,"tweetType":1,"viewCount":3210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":288985910763760,"gmtCreate":1711577748328,"gmtModify":1711577752303,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Ohh,how good,need sell ...","listText":"Ohh,how good,need sell ...","text":"Ohh,how good,need sell ...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/288985910763760","repostId":"2422394399","repostType":2,"isVote":1,"tweetType":1,"viewCount":2578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":259461551751368,"gmtCreate":1704355467931,"gmtModify":1704355472099,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Nio is pain,nothing more.","listText":"Nio is pain,nothing more.","text":"Nio is pain,nothing more.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/259461551751368","repostId":"2400820650","repostType":2,"repost":{"id":"2400820650","kind":"highlight","pubTimestamp":1704355200,"share":"https://ttm.financial/m/news/2400820650?lang=en_US&edition=fundamental","pubTime":"2024-01-04 16:00","market":"us","language":"en","title":"Is Nio a Top EV Stock for 2024?","url":"https://stock-news.laohu8.com/highlight/detail?id=2400820650","media":"Motley Fool","summary":"Nio may be a trendy investment, but there are better EV stock picks available.","content":"<div>\n<p>Nio is much smaller than other EV giants in China.The company isn't profitable and is running out of cash.While some trends from 2023 may disappear, one that likely won't is the growing percentage of ...</p>\n\n<a href=\"https://www.fool.com/investing/2024/01/03/is-nio-a-top-ev-stock-for-2024/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Nio a Top EV Stock for 2024?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Nio a Top EV Stock for 2024?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-04 16:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2024/01/03/is-nio-a-top-ev-stock-for-2024/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nio is much smaller than other EV giants in China.The company isn't profitable and is running out of cash.While some trends from 2023 may disappear, one that likely won't is the growing percentage of ...</p>\n\n<a href=\"https://www.fool.com/investing/2024/01/03/is-nio-a-top-ev-stock-for-2024/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU0971096721.USD":"富达环球金融服务 A","BK4581":"高盛持仓","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","LU0149725797.USD":"汇丰美国股市经济规模基金","BK4585":"ETF&股票定投概念","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","BK4534":"瑞士信贷持仓","LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0742534661.SGD":"Fidelity America A-SGD (hedged)","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4176":"多领域控股","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","IE00B775SV38.USD":"NEUBERGER BERMAN US MULTICAP OPPORTUNITIES \"A\" (USD) ACC","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU0234572021.USD":"高盛美国核心股票组合Acc","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU0048573561.USD":"FIDELITY AMERICA \"A\" (USD) INC","LU0053666078.USD":"摩根大通基金-美国股票A（离岸）美元","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0251142724.SGD":"Fidelity America A-SGD","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","BK4550":"红杉资本持仓","BK4588":"碎股","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","09866":"蔚来-SW","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","NIO":"蔚来","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","NIO.SI":"蔚来"},"source_url":"https://www.fool.com/investing/2024/01/03/is-nio-a-top-ev-stock-for-2024/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2400820650","content_text":"Nio is much smaller than other EV giants in China.The company isn't profitable and is running out of cash.While some trends from 2023 may disappear, one that likely won't is the growing percentage of the global automobile fleet converting to electric vehicles (EVs). In the U.S., less than 10% of total automobile sales are now EVs. In China, that percentage is higher, with battery electric vehicles (BEVs) accounting for 25% of new sales in September 2023.This makes China a critical EV market for investors, and Nio is a company that often comes up when researching Chinese EV companies. With EVs slated to capture even more market share in 2024, is Nio a good buy right now?Nio is not China's largest EV producerAlthough Nio is a popular Chinese EV investment for U.S. investors, it's far from China's biggest EV maker. That title belongs to BYD (BYDDY). In December, Nio delivered over 18,000 vehicles, up 14% year over year. For 2023, it delivered over 160,000 vehicles, up 31%.In comparison, BYD produced over 3 million cars in 2023 and nearly 309,000 in December alone. So size-wise, Nio isn't even close to BYD.But the two are serving different markets. Nio is focused on the luxury segment, while BYD offers more affordable EVs. As a result, Nio will likely never reach the same scale as BYD, but that doesn't disqualify Nio as a potential investment.However, it should be noted that China's economy isn't doing particularly well. This could spell trouble for Nio if drivers look to cheaper options instead of more premium ones. While it remains to be seen if this will have an effect in 2024, it's something to consider before taking a position in Nio.Another consideration is its financials.Nio is unprofitable and burning cash quicklyNio is a rapidly growing company. In the third quarter, its sales rose 46% year over year to RMB17.4 billion. However, it isn't profitable. Nio lost RMB4.8 billion ($658 million) from operations, which isn't far from breaking even. With RMB5.3 billion in cash on hand ($726 million), Nio is also in danger of running out of money.However, in mid-December 2023, Nio announced a $2.2 billion investment from U.S. investment firm CYVN. This will shore up Nio's finances momentarily, but the company is in a race with the clock to become profitable.The fourth quarter also isn't looking the greatest. Nio only projected to deliver between 47,000 and 49,000 vehicles, yet exceeded expectations by delivering over 50,000. However, thanks to price cuts, Nio's revenue was only supposed to grow by about 4% on the high end. While the delivery beat may increase its growth rate, growing revenue in the mid-single digits isn't a great recipe for a company trying to break even.Despite that, Nio trades at a premium to established China EV player BYD.NIO PS Ratio data by YChartsConsidering that BYD grew its Q3 revenue at nearly 40%, purchasing Nio instead of BYD doesn't seem like a smart investment move.There's a reason why smart investment firms like Berkshire Hathaway own BYD stock, not Nio (Berkshire owns 8% of BYD). Investing in China is already hard enough; investors don't need to add more difficulty by investing in upstarts in a highly competitive industry.While Nio may have a great product, the stock doesn't seem worth the risk.","news_type":1,"symbols_score_info":{"NIO":0.9,"09866":1.1,"NIO.SI":1}},"isVote":1,"tweetType":1,"viewCount":3065,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":210190990938240,"gmtCreate":1692338510020,"gmtModify":1692338515147,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Hold before dye","listText":"Hold before dye","text":"Hold before dye","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/210190990938240","repostId":"2360039064","repostType":2,"repost":{"id":"2360039064","kind":"highlight","pubTimestamp":1692337753,"share":"https://ttm.financial/m/news/2360039064?lang=en_US&edition=fundamental","pubTime":"2023-08-18 13:49","market":"us","language":"en","title":"Got $5,000? 3 Stocks to Hold for the Next 20 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2360039064","media":"Motley Fool","summary":"These industry-leading businesses need to be on your radar as potential long-term investments.","content":"<div>\n<p>The world is inherently unpredictable. No one could have thought that a global pandemic would happen and bring the economy to a screeching halt. Moreover, supply chain issues, soaring inflation, and ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/08/17/got-5000-3-stocks-to-hold-for-the-next-20-years/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $5,000? 3 Stocks to Hold for the Next 20 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $5,000? 3 Stocks to Hold for the Next 20 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-18 13:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/08/17/got-5000-3-stocks-to-hold-for-the-next-20-years/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The world is inherently unpredictable. No one could have thought that a global pandemic would happen and bring the economy to a screeching halt. Moreover, supply chain issues, soaring inflation, and ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/08/17/got-5000-3-stocks-to-hold-for-the-next-20-years/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克","AAPL":"苹果","SBUX":"星巴克"},"source_url":"https://www.fool.com/investing/2023/08/17/got-5000-3-stocks-to-hold-for-the-next-20-years/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2360039064","content_text":"The world is inherently unpredictable. No one could have thought that a global pandemic would happen and bring the economy to a screeching halt. Moreover, supply chain issues, soaring inflation, and rapidly rising interest rates followed. This makes trying to invest with a 20-year time horizon seem almost impossible. But there are some clues that investors can identify in specific businesses that warrant owning them for this long. It's all about durability. Let's take a closer look at why Apple, Nike, and Starbucks are three stocks to evenly split a $5,000 investment in, with the intention of holding them for the next 20 years. AppleThe past two decades have seen Apple introduce game-changing products like the iPod, iPhone, iPad, Watch, and AirPods, all to incredible enthusiasm from consumers. And in the past several years, the company's services segment has been posting strong growth, thanks to offerings like Music, TV+, and Pay. This successful history of innovation and focus on beautiful hardware and user-friendly software is exactly why Apple should remain one of the most valuable companies well into the future. The powerful brand resonates with consumers, and it has created a business that seems to print money. Apple generated $111 billion of free cash flow in fiscal 2022 (ended Sept. 24). And as of July 1, the company had $166.5 billion of cash, cash equivalents, and marketable securities on its balance sheet compared to $105.3 billion of debt. This financial strength means that Apple has the resources to invest in new ideas that could move the needle from a growth perspective, like augmented and virtual reality initiatives. After producing a stellar return of 243% in the last five years and a 38% return this year alone (as of Aug. 14), Apple shares aren't cheap, trading at a price-to-earnings ratio of 30. Nonetheless, it might be a safe stock to still consider buying. NikeHaving been founded in 1964, Nike has the longest operating history of all the companies on this list. And that longevity has benefited the business in two ways. For starters, Nike's brand presence is unmatched. Its clothing and footwear products are in huge demand across the world, and customers are willing to pay premium prices for them. The company's quarterly gross margin has averaged 44.3% over the past five years. Being successful for such a long period of time means that Nike has been forced to adapt to change in order to ensure its ultimate survival. The shift to digital and e-commerce and away from brick-and-mortar demonstrates management's ability to think about changes in consumer behavior. Nike is focused on relying less on wholesale distributors and instead leaning into its own channels.The leadership team wants half of all revenue to eventually come from digital sales. This shouldn't be a problem considering that Nike's Consumer Direct Acceleration strategy, which started in 2020, prioritizes digitizing operations. The next 20 years could look very different from the last 20. That's because most of Nike's gains are poised to come from the fast-growing Greater China region, which represented 14% of company revenue in the most recent fiscal quarter (the fourth quarter of 2023, ended May 31).  StarbucksWith over 37,000 stores worldwide as of July 2, Starbucks is already a ubiquitous brand. But executives believe the business can have 55,000 locations open by the end of 2030. Consequently, the expansionary runway still looks to be very big, with a lot of the growth coming from China. Like Apple and Nike, Starbucks' brand is the key to its success. And it will continue to play a huge part in how the company fares going forward. Starbucks has been able to sell a commoditized product at premium prices, leading to sizable growth and profitability, primarily because it has found a way to encourage consumers to spend more. Starbucks' top-notch rewards program, with 31.4 million active accounts in the U.S., is incredibly valuable. It not only drives customer loyalty that leads to repeat visits, but it also provides the company with an effective way to collect data that can inform product and marketing decisions. With a high degree of certainty, investors can be sure that Starbucks will be doing the same thing in 20 years that it's doing today. By not inviting much technological disruption, the business is better insulated from the threat of competition. And this raises the chances that it is still a successful enterprise two decades from now.","news_type":1,"symbols_score_info":{"AAPL":0.9,"SBUX":0.9,"NKE":0.9}},"isVote":1,"tweetType":1,"viewCount":3262,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":209187705987096,"gmtCreate":1692108200492,"gmtModify":1692108205292,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Go upp,just need wait.","listText":"Go upp,just need wait.","text":"Go upp,just need wait.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/209187705987096","repostId":"2359811243","repostType":2,"repost":{"id":"2359811243","kind":"highlight","pubTimestamp":1692100620,"share":"https://ttm.financial/m/news/2359811243?lang=en_US&edition=fundamental","pubTime":"2023-08-15 19:57","market":"us","language":"en","title":"Alibaba Stock Reveals Doubts That Latest China Rate Cuts Can Save Economy","url":"https://stock-news.laohu8.com/highlight/detail?id=2359811243","media":"marketwatch","summary":"Alibaba stock was muted despite a move from China’s central bank to boost consumption.              Dreamstime               The stock market doesn’t believe that the latest stimulus from China will b","content":"<html><body><div itemprop=\"articleBody\"> <div> <div> <div aria-hidden=\"true\"></div> </div> </div> <div> <div> <div aria-label=\"Listen to Article\" role=\"region\" tabindex=\"-1\"> </div> </div> </div> <div> <figure itemscope=\"\" itemtype=\"http://schema.org/ImageObject\"> <div> <img itemprop=\"contentUrl\" sizes=\"(max-width: 639px) 100vw, (max-width: 979px) 300px, (max-width: 1299px) 300px, 300px\" src=\"https://images.barrons.com/im-803045?width=639&amp;height=426\" srcset=\"https://images.barrons.com/im-803045?width=300&amp;size=1.5 300w, https://images.barrons.com/im-803045?width=639&amp;size=1.5 639w, https://images.barrons.com/im-803045?width=639&amp;size=1.5&amp;pixel_ratio=1.5 958w, https://images.barrons.com/im-803045?width=639&amp;size=1.5&amp;pixel_ratio=2 1278w, https://images.barrons.com/im-803045?width=639&amp;size=1.5&amp;pixel_ratio=3 1917w\" title=\"\"/> </div> <figcaption itemprop=\"caption\"> <h4>Alibaba stock was muted despite a move from China’s central bank to boost consumption.</h4> <span itemprop=\"creator\">             Dreamstime           </span> </figcaption> </figure> </div> <p>The stock market doesn’t believe that the latest stimulus from China will be enough to save the world’s second-largest economy. Just look at          Alibaba<span>.</span> </p> <p>Shares in          Alibaba        (ticker: BABA) fell 0.7% in U.S. premarket trading on Tuesday, poised to extend declines after the stock dropped 2.4% on Monday. It’s not the move shareholders want to see after China’s central bank cut a spate of lending rates to shore up the country’s economy and boost consumption. At the start of the year, investors were expecting a strong recovery in 2023 after pandemic lockdowns were lifted.</p> <div> <p>The People’s Bank of China on Tuesday lowered its seven-day reverse repo rate, a main rate for short-term bank liquidity, to 1.8% from 1.9%. The central bank also cut its one-year medium-term lending facility rate to 2.5% from 2.65%—the biggest downshift of that benchmark since April 2020 and the early days of the Covid-19 pandemic.</p> <p>“The most urgent goal now is to stimulate household consumption, and it is necessary to use all reasonable, legally compliant and economic channels to put money in residents’ pockets,” Cai Fang, a member of the PBOC’s monetary policy committee, wrote in statement published on local social media late Monday, Bloomberg reported.</p> <p>One of China’s largest companies and an e-commerce giant, Alibaba is a good bellwether for domestic economic trends and is sensitive to the Chinese consumer. The          Dow Jones Industrial Average        and          S&amp;P 500        are both set to fall on Tuesday amid a bevy of pressures, but a slip in Alibaba stock signals that investors are specifically gloomy about the efficacy of what increasingly looks like desperate Chinese stimulus.</p> <p>China’s economy fell into a rut in 2022 as the government’s severe zero-Covid lockdown policies stifled a recovery from the pandemic felt elsewhere. Hopes were high for 2023 to deliver a rebound, but it has yet to materialize. </p> <p>“Monetary stimulus is of limited use in the current environment and won’t be enough, on its own at least, to put a floor beneath growth,” Julian Evans-Pritchard, the head of China economics at research group Capital Economics, wrote in a Tuesday note.</p> <p>Multiple metrics now suggest China’s economic slowdown is getting worse—a trend that is weighing on global markets—including underwhelming retail sales and industrial production data released on Tuesday. A crisis in the sprawling and distressed property sector, and the possibility of spillover, add to the gloom.</p> <p>“But the PBOC tends to use changes in policy rates as a signalling tool, with the heavy lifting being done by other tools such as adjustments to reserve requirements and bank loan quotas,” Evans-Pritchard added. “Today’s cut suggests that these tools will be deployed too, consistent with the PBOC’s promise of further monetary easing.”</p> <p>But so far the move looks like another disappointment. While, as Evans-Pritchard said, it telegraphs even more action, it puts the emphasis on a maybe-next-time approach for investors currently looking for the upside in the selloff across Chinese names like Alibaba.</p> <p>Write to Jack Denton at jack.denton@barrons.com</p> </div> </div></body></html>","source":"mwatch_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba Stock Reveals Doubts That Latest China Rate Cuts Can Save Economy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba Stock Reveals Doubts That Latest China Rate Cuts Can Save Economy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-15 19:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/alibaba-stock-doubts-china-rate-cuts-pandemic-ecb8e50e?mod=newsviewer_click><strong>marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Alibaba stock was muted despite a move from China’s central bank to boost consumption.              Dreamstime               The stock market doesn’t believe that the latest stimulus from China will ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/alibaba-stock-doubts-china-rate-cuts-pandemic-ecb8e50e?mod=newsviewer_click\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://images.barrons.com/im-803045?size=1.777777777777778&width=220 220w","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1048596156.SGD":"Blackrock Asian Growth Leaders A2 SGD-H","BK4503":"景林资产持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4122":"互联网与直销零售","BK4575":"芯片概念","LU0821914370.USD":"贝莱德亚洲成长领袖A2","BK4502":"阿里概念","BK4558":"双十一","BK4587":"ChatGPT概念","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","LU1046422090.SGD":"Fidelity Pacific A-SGD","BABA":"阿里巴巴","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","BK4505":"高瓴资本持仓","BK4535":"淡马锡持仓","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC","BK4504":"桥水持仓","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","BK4538":"云计算","BK4579":"人工智能","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","BK4588":"碎股","LU0651946864.USD":"贝莱德新兴市场股票收益A2","BK4548":"巴美列捷福持仓","LU1880383366.USD":"东方汇理中国股票基金 A2 (C)","BK4565":"NFT概念","LU1051768304.USD":"贝莱德新兴市场股票收益A6","LU1688375341.USD":"贝莱德中国灵活股票基金","09988":"阿里巴巴-W","BK4220":"综合零售","BK4524":"宅经济概念","BK4554":"元宇宙及AR概念","BK4581":"高盛持仓","LU1515016050.SGD":"Blackrock Emerging Markets Equity Income A6 SGD-H","BK4527":"明星科技股","BK4531":"中概回港概念","BK4526":"热门中概股"},"source_url":"https://www.marketwatch.com/articles/alibaba-stock-doubts-china-rate-cuts-pandemic-ecb8e50e?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2359811243","content_text":"Alibaba stock was muted despite a move from China’s central bank to boost consumption.              Dreamstime               The stock market doesn’t believe that the latest stimulus from China will be enough to save the world’s second-largest economy. Just look at          Alibaba.  Shares in          Alibaba        (ticker: BABA) fell 0.7% in U.S. premarket trading on Tuesday, poised to extend declines after the stock dropped 2.4% on Monday. It’s not the move shareholders want to see after China’s central bank cut a spate of lending rates to shore up the country’s economy and boost consumption. At the start of the year, investors were expecting a strong recovery in 2023 after pandemic lockdowns were lifted.  The People’s Bank of China on Tuesday lowered its seven-day reverse repo rate, a main rate for short-term bank liquidity, to 1.8% from 1.9%. The central bank also cut its one-year medium-term lending facility rate to 2.5% from 2.65%—the biggest downshift of that benchmark since April 2020 and the early days of the Covid-19 pandemic. “The most urgent goal now is to stimulate household consumption, and it is necessary to use all reasonable, legally compliant and economic channels to put money in residents’ pockets,” Cai Fang, a member of the PBOC’s monetary policy committee, wrote in statement published on local social media late Monday, Bloomberg reported. One of China’s largest companies and an e-commerce giant, Alibaba is a good bellwether for domestic economic trends and is sensitive to the Chinese consumer. The          Dow Jones Industrial Average        and          S&P 500        are both set to fall on Tuesday amid a bevy of pressures, but a slip in Alibaba stock signals that investors are specifically gloomy about the efficacy of what increasingly looks like desperate Chinese stimulus. China’s economy fell into a rut in 2022 as the government’s severe zero-Covid lockdown policies stifled a recovery from the pandemic felt elsewhere. Hopes were high for 2023 to deliver a rebound, but it has yet to materialize.  “Monetary stimulus is of limited use in the current environment and won’t be enough, on its own at least, to put a floor beneath growth,” Julian Evans-Pritchard, the head of China economics at research group Capital Economics, wrote in a Tuesday note. Multiple metrics now suggest China’s economic slowdown is getting worse—a trend that is weighing on global markets—including underwhelming retail sales and industrial production data released on Tuesday. A crisis in the sprawling and distressed property sector, and the possibility of spillover, add to the gloom. “But the PBOC tends to use changes in policy rates as a signalling tool, with the heavy lifting being done by other tools such as adjustments to reserve requirements and bank loan quotas,” Evans-Pritchard added. “Today’s cut suggests that these tools will be deployed too, consistent with the PBOC’s promise of further monetary easing.” But so far the move looks like another disappointment. While, as Evans-Pritchard said, it telegraphs even more action, it puts the emphasis on a maybe-next-time approach for investors currently looking for the upside in the selloff across Chinese names like Alibaba. Write to Jack Denton at jack.denton@barrons.com","news_type":1,"symbols_score_info":{"09988":0.6,"BABA":0.9}},"isVote":1,"tweetType":1,"viewCount":3327,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":206402351644776,"gmtCreate":1691400722071,"gmtModify":1691400725173,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Thieves","listText":"Thieves","text":"Thieves","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/206402351644776","repostId":"2357463377","repostType":2,"isVote":1,"tweetType":1,"viewCount":3178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":202109998841904,"gmtCreate":1690349849449,"gmtModify":1690349852467,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/202109998841904","repostId":"2354337617","repostType":2,"isVote":1,"tweetType":1,"viewCount":3233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9970060341,"gmtCreate":1683723421384,"gmtModify":1683723424832,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Thieves","listText":"Thieves","text":"Thieves","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9970060341","repostId":"2334220259","repostType":2,"repost":{"id":"2334220259","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1683652091,"share":"https://ttm.financial/m/news/2334220259?lang=en_US&edition=fundamental","pubTime":"2023-05-10 01:08","market":"us","language":"en","title":"BRIEF-Tonix Pharmaceuticals Announces 1-For-6.25 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2334220259","media":"Reuters","summary":"May 9 (Reuters) - Tonix Pharmaceuticals Holding Corp:   * TONIX PHARMACEUTICALS ANNOUNCES 1-FOR-6.25","content":"<html><body><p>May 9 (Reuters) - Tonix Pharmaceuticals Holding Corp:</p><p>   * TONIX PHARMACEUTICALS ANNOUNCES 1-FOR-6.25 REVERSE STOCK SPLIT</p><p>   * TONIX PHARMACEUTICALS HOLDING CORP - REVERSE STOCK SPLIT WILL BE EFFECTIVE FOR TRADING PURPOSES AS OF COMMENCEMENT OF TRADING ON MAY 10, 2023</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Tonix Pharmaceuticals Announces 1-For-6.25 Reverse Stock Split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Tonix Pharmaceuticals Announces 1-For-6.25 Reverse Stock Split\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-05-10 01:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>May 9 (Reuters) - Tonix Pharmaceuticals Holding Corp:</p><p>   * TONIX PHARMACEUTICALS ANNOUNCES 1-FOR-6.25 REVERSE STOCK SPLIT</p><p>   * TONIX PHARMACEUTICALS HOLDING CORP - REVERSE STOCK SPLIT WILL BE EFFECTIVE FOR TRADING PURPOSES AS OF COMMENCEMENT OF TRADING ON MAY 10, 2023</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4583":"猴痘概念","TNXP":"Tonix Pharmaceuticals Holding Co","BK4139":"生物科技"},"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2334220259","content_text":"May 9 (Reuters) - Tonix Pharmaceuticals Holding Corp:   * TONIX PHARMACEUTICALS ANNOUNCES 1-FOR-6.25 REVERSE STOCK SPLIT   * TONIX PHARMACEUTICALS HOLDING CORP - REVERSE STOCK SPLIT WILL BE EFFECTIVE FOR TRADING PURPOSES AS OF COMMENCEMENT OF TRADING ON MAY 10, 2023Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"890260854":1,"TNXP":1}},"isVote":1,"tweetType":1,"viewCount":2408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9970017771,"gmtCreate":1683716592893,"gmtModify":1683716597032,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"THIEVES","listText":"THIEVES","text":"THIEVES","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9970017771","repostId":"2334264278","repostType":2,"repost":{"id":"2334264278","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1683654180,"share":"https://ttm.financial/m/news/2334264278?lang=en_US&edition=fundamental","pubTime":"2023-05-10 01:43","market":"nz","language":"en","title":"Tonix Pharmaceuticals Shares Down 20%, Company Plans Another Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2334264278","media":"Dow Jones","summary":"By Josh Beckerman \n\n\n \n\n\n  Shares of Tonix Pharmaceuticals Holding fell 20% to 41 cents on Tuesday a","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Tonix Pharmaceuticals Holding fell 20% to 41 cents on Tuesday after the company said it would conduct its second reverse stock split in less than a year. \n</p>\n<p>\n  The shares approaching their 52-week low of 29 cents and have fallen 90% in the last 12 months. \n</p>\n<p>\n  The biopharmaceutical company said a 1-for-6.25 reverse split will be effective for trading purposes on Wednesday. The move is intended to increase the per-share trading price to meet Nasdaq's $1 minimum bid price requirement. \n</p>\n<p>\n  The company completed a 1-for-32 reverse split effective on May 17, 2022. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 09, 2023 13:43 ET (17:43 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tonix Pharmaceuticals Shares Down 20%, Company Plans Another Reverse Stock Split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTonix Pharmaceuticals Shares Down 20%, Company Plans Another Reverse Stock Split\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2023-05-10 01:43</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of Tonix Pharmaceuticals Holding fell 20% to 41 cents on Tuesday after the company said it would conduct its second reverse stock split in less than a year. \n</p>\n<p>\n  The shares approaching their 52-week low of 29 cents and have fallen 90% in the last 12 months. \n</p>\n<p>\n  The biopharmaceutical company said a 1-for-6.25 reverse split will be effective for trading purposes on Wednesday. The move is intended to increase the per-share trading price to meet Nasdaq's $1 minimum bid price requirement. \n</p>\n<p>\n  The company completed a 1-for-32 reverse split effective on May 17, 2022. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 09, 2023 13:43 ET (17:43 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TNXP":"Tonix Pharmaceuticals Holding Co","BK4139":"生物科技","BK4583":"猴痘概念"},"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2334264278","content_text":"By Josh Beckerman \n\n\n \n\n\n  Shares of Tonix Pharmaceuticals Holding fell 20% to 41 cents on Tuesday after the company said it would conduct its second reverse stock split in less than a year. \n\n\n  The shares approaching their 52-week low of 29 cents and have fallen 90% in the last 12 months. \n\n\n  The biopharmaceutical company said a 1-for-6.25 reverse split will be effective for trading purposes on Wednesday. The move is intended to increase the per-share trading price to meet Nasdaq's $1 minimum bid price requirement. \n\n\n  The company completed a 1-for-32 reverse split effective on May 17, 2022. \n\n\n \n\n\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 09, 2023 13:43 ET (17:43 GMT)\n\n\n  Copyright (c) 2023 Dow Jones & Company, Inc.","news_type":1,"symbols_score_info":{"890260854":1,"TNXP":1}},"isVote":1,"tweetType":1,"viewCount":1690,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9947676400,"gmtCreate":1683127120400,"gmtModify":1683127124299,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"One more theft of thieves...","listText":"One more theft of thieves...","text":"One more theft of thieves...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9947676400","repostId":"2332985143","repostType":2,"repost":{"id":"2332985143","kind":"highlight","weMediaInfo":{"introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"media_name":"GlobeNewswire","id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"pubTimestamp":1682956200,"share":"https://ttm.financial/m/news/2332985143?lang=en_US&edition=fundamental","pubTime":"2023-05-01 23:50","market":"hk","language":"en","title":"Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=2332985143","media":"GlobeNewswire","summary":"SAN DIEGO, May  01, 2023  (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced that on","content":"<html><body><p>SAN DIEGO, May  01, 2023  (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a>, Inc. (BNGO), today announced that on May 1, 2023, it published an open letter to stockholders in support of its proposals at its upcoming annual meeting of stockholders, a copy of which is included at the end of this press release. <br/></p> <p><strong>Details of the Annual Meeting of Stockholders</strong></p> <p>The annual meeting of stockholders will be held virtually, via live webcast at www.virtualshareholdermeeting.com/BNGO2023, on June 14, 2023, at 10:00 a.m. Pacific Time. Stockholders of record as of April 24, 2023, may vote at the annual meeting or by proxy over the telephone, through the internet or using the Notice of Internet Availability of Proxy Materials mailed to such stockholders. Stockholders may change their vote at any time before the final vote at the annual meeting.</p> <p>Details regarding voting procedures are included in the Company’s proxy statement for the annual meeting, filed with the U.S. Securities and Exchange Commission on April 28, 2023.</p> <p><strong>About Bionano Genomics</strong></p> <p>Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, the Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit www.bionano.com, www.bionanolaboratories.com or www.biodiscovery.com.</p> <p><strong>Letter to Stockholders</strong></p> <p>May 1, 2023</p> <p>Re: <strong><u>Stockholder Action Letter: Request for Vote!</u></strong></p> <p>Dear Fellow Stockholders:</p> <p>I am writing to ask for your support on the proposals described in our 2023 Definitive Proxy Statement, filed with the SEC on April 28, 2023. In particular, I am asking you to vote FOR Proposal 4, the reverse split proposal. We believe that if the reverse split proposal is not approved, our ability to prudently raise capital may be compromised, our ability to attract and retain critical talent may be impacted, and our ability to act strategically with regard to the use of our equity in future opportunistic transactions may be constrained, among other things. Implementing a reverse split would provide the flexibility we need to use our common stock for business and/or financial purposes. Our reverse split proposal is a request to support a constructive tool that we believe is essential to achieving our long-term goals.</p> <p><strong>Bionano’s business has been progressing and still requires ongoing innovation and investment.</strong></p> <p>Bionano is focused on transforming traditional cytogenetic workflows into a modern, molecular workflow based on optical genome mapping (OGM). Current cytogenetic workflows are antiquated, slow and fail to provide useful results in roughly 50% of cases. Numerous published studies from laboratories and hospitals around the world have demonstrated that OGM has the potential to replace traditional cytogenetic methods, including fluorescence <em>in situ</em> hybridization (FISH), karyotyping, southern blot and chromosomal microarrays, with the OGM workflow as an alternative that is streamlined, yields useful results in substantially more samples, is less costly, and is simpler and faster. OGM has applications in cancer, genetic disease and cell bioprocessing quality control for drug development.</p> <p>We have made extraordinary progress since the summer of 2020, enabled by the advancements in market development and product development, and accelerated by the capital we raised in early 2021.</p> <ul><li><strong>Our annual revenue grew 227% between 2020 and 2022,</strong> from $8.5M in 2020, to $17.9M in 2021, to $27.8M in 2022</li><li><strong>The installed base of Saphyr® systems for OGM grew 147%</strong> <strong>between 2020 and 2022, </strong>from 97 as of the end of 2020, to 164 as of the end of 2021, to 240 as of the end of 2022</li><li><strong>Sales of nanochannel array flow cells grew substantially </strong>with 6,013 sold in 2020, 12,518 sold in 2021 and 15,375 sold in 2022</li><li><strong>Performance of our products has improved significantly</strong> since the launch of the Saphyr system in 2017, including a 13-fold increase in OGM throughput and a reduction in the price of analyzing a single genome from $1,500 to as low as $450</li><li><strong>Publications describing OGM in clinical research grew substantially</strong> from 23 as of the end of 2020, to 53 as of the end of 2021, to 108 as of the end of 2022 and the number of published clinical genomes using OGM grew from 214 in 2020, to 1,478 in 2021, to 3,092 at the end of 2022</li><li><strong>Our product portfolio in clinical services, which began with an acquisition in 2020, has expanded to include OGM-based laboratory developed tests (LDTs)</strong> for use in diagnosing a genetic disease known as facioscapulohumeral dystrophy (FSHD) and blood cancers such as different forms of leukemia</li><li><strong>Bionano has completed two acquisitions</strong> that we believe will enable delivery of a streamlined and simplified end-to-end workflow for OGM, a key requirement for routine use customers<br/></li></ul> <p>We believe the progress made in the preceding three years reflects the early adoption of OGM by clinical researchers seeking to adopt a new and novel method and demonstrate its utility. Going forward, our strategy for 2023 through 2025 is to continue that momentum and, among other things, achieve between a 30% to 50% compound annual growth rate for revenue. Our 2023 to 2025 strategy includes:</p> <ul><li><strong>Develop and launch significant new products</strong> <ul><li>Our next generation optical genome mapping system will have an increased throughput of approximately four times that of the current Saphyr system at launch and is expected to eventually reach a 13-fold increase in throughput</li><li>A version of our VIA™ software (currently named NxClinical™) which will integrate OGM data for data visualization, analysis and interpretation alongside next-generation sequencing (NGS) and other data types</li><li>A consumable and protocol for isolation of ultra-high molecular weight (UHMW) DNA for use with isotachophoresis (ITP) on the Ionic® system for automated nucleic acid isolation</li></ul> </li><li><strong>Continue developing the market for OGM and clearing the path for reimbursement</strong> of OGM through clinical research and seek FDA clearance to market OGM for clinical use <ul><li>Our clinical studies for genome analysis in pre-natal and post-natal conditions, blood cancers and solid-tumor cancers are expected to continue. We believe the volume of samples analyzed and published combined with health-economic analysis have the potential to result in OGM being included in professional societies’ guidelines for clinical testing.</li><li>We plan to submit an application for a local coverage decision (LCD) to Medicare for reimbursement coverage of OGM for hematologic malignancies.</li><li>We will begin preliminary pre-submission discussion with the FDA regarding clearance of OGM in 2023.</li></ul> </li><li><strong>Retaining and adding key talent</strong> to expand our commercial footprint globally, to develop new applications of OGM and to translate OGM into a technique that is used routinely throughout genome analysis<br/></li></ul> <p><strong>A vote FOR Proposal 4 would enable management to invest prudently in the business and to continue driving progress</strong></p> <p>We believe it is imperative for stockholders to authorize Bionano’s Board of Directors to effect a reverse split, as outlined in Proposal 4, to continue and potentially accelerate the momentum begun in 2020 and to deliver on the strategy outlined above. There are three primary outcomes of a reverse split that management believes are critical to realize:</p> <ul><li><strong>A reverse split would result in potential improvement in the marketability and liquidity of our common stock. </strong>We believe that a higher stock price would make our common stock more attractive to a broader range of institutional and other investors, which we believe would improve the marketability and liquidity of our common stock and increase interest and trading in our common stock, including by long-term institutional investors and funds who may not find our shares attractive at its current trading price.</li><li><strong>A reverse split would effectively increase the number of shares of common stock available to issue.</strong> A reverse split would decrease the number of shares of common stock outstanding but would not impact the number of our authorized shares of common stock. At this time, the current number of authorized and unreserved shares available for future issuance: (i) is insufficient to meet our anticipated future capital requirements through equity financings, including pursuant to our “at-the-market” sales agreement with Cowen and Company, LLC; (ii) is insufficient to provide future equity incentive opportunities, which may impact our ability to attract and retain the talent we believe is important to the success of the company; and (iii) may unduly constrain our ability to act strategically with regard to the use of our equity in future opportunistic transactions. Implementing a reverse split would provide the flexibility we need to use our common stock for business and/or financial purposes.</li><li><strong>A reverse split would support ongoing compliance with Nasdaq listing requirements</strong>. Our common stock is listed on the Nasdaq Capital Market, which has as one of its continued listing requirements a minimum bid price of at least $1.00 per share. The closing price of our common stock for the ten consecutive business days between April 17 and April 28 was below $1.00, reaching a low of $0.68 per share on April 21. If the closing price of our common stock remains below $1.00 for 30 consecutive business days, we would fall out of compliance with the minimum bid price requirement. If we were to fail to regain compliance, our common stock could be subject to delisting from the Nasdaq Capital Market, which may lead to a loss of confidence of our customers, collaborators, vendors and employees, which could do irreparable harm to our business and future prospects.<br/></li></ul> <p>In order to ensure that we can respect the voices of those who vote, we issued one share of Series A Preferred Stock to the Chairman of our Board of Directors. The share of Series A Preferred Stock has 3,000,000,000 votes, but those votes must be voted in the same proportion as the votes cast by our common stockholders and can only vote on Proposal 4. The votes of the preferred share would not change the voice of shareholders who vote but would simply mirror their votes so that in the event there are more than a majority of the votes cast in favor of Proposal 4, there should be enough votes to pass the proposal. The Series A Preferred Stock will be redeemed and retired automatically after approval of a reverse stock split proposal pursuant to its terms.</p> <p>For other companies, a request for authorization to effect a reverse split may reflect a sign of distress. We believe that the reverse split proposal is not a sign of distress for Bionano. Instead, it is a mechanism to enable management to prudently raise capital in support of our long-term strategy.</p> <p>Please support management by voting FOR all proxy proposals. Most importantly please support management by voting FOR Proposal 4.</p> <p>Sincerely,</p> <p>Erik Holmlin, PhD<br/>President and CEO<br/>Bionano Genomics, Inc.</p> <p><strong><em>Forward-Looking Statements</em></strong></p> <p><em>This letter contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “continue,” “could,” “expect,” “intend,” “may,” “plan,” “will,” “should” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify these forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: (1) the anticipated benefits of the reverse split, including on the marketability and liquidity of our common stock, our ability to execute on our long-term strategy and our compliance with Nasdaq listing requirements; (2) the utility of OGM for applications cancer, genetic disease and cell bioprocessing quality control, and its ability to complement or replace traditional cytogenomic methods for analysis of structural variations; (3) our anticipated goals and milestones for OGM and Bionano, including improved adoption of OGM, reimbursement of OGM through clinical research and FDA clearance to market OGM for clinical use; (4) our growth prospects and estimates regarding future financial performance and operating results; (5) our future products and features, including the performance of these products and their sample processing capacity; and (6) our anticipated growth strategies and anticipated trends in our business. Each of these forward-looking statements involves risks and uncertainties. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of geopolitical and macroeconomic developments, such as recent and potential future bank failures, the ongoing Ukraine-Russia conflict, related sanctions and the COVID-19 pandemic, on our business and the global economy; challenges inherent in developing, manufacturing and commercializing products; our ability to further deploy new products and applications and expand the markets for our technology platforms; third parties’ abilities to manufacture our instruments and consumables; our assumptions, expectations and beliefs regarding future growth of the business and the markets in which we operate; the completion and success of our clinical studies; the success of products competitive with our own; changes in our strategic and commercial plans; the application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions; study results that are different from or contradict the results presented in this letter; our assumptions and estimates regarding our future financial performance and results of operations; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2022 and in other filings subsequently made by us with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as required by law.</em></p> <p><strong>CONTACTS</strong></p> <p><strong>Company Contact:</strong><br/>Erik Holmlin, CEO<br/>Bionano Genomics, Inc.<br/>+1 (858) 888-7610<br/>eholmlin@bionano.com</p> <p><strong>Investor Relations:</strong><br/>David Holmes<br/>Gilmartin Group<br/>+1 (858) 888-7625<br/>IR@bionano.com</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/OWQ4OTgzNDctZTBhNy00YzlhLTkzOTAtNjcyMDg0ZWQ2NDk5LTUwMDA1MjUyMQ==/tiny/Bionano-Genomics.png\"/></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time\">2023-05-01 23:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>SAN DIEGO, May  01, 2023  (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a>, Inc. (BNGO), today announced that on May 1, 2023, it published an open letter to stockholders in support of its proposals at its upcoming annual meeting of stockholders, a copy of which is included at the end of this press release. <br/></p> <p><strong>Details of the Annual Meeting of Stockholders</strong></p> <p>The annual meeting of stockholders will be held virtually, via live webcast at www.virtualshareholdermeeting.com/BNGO2023, on June 14, 2023, at 10:00 a.m. Pacific Time. Stockholders of record as of April 24, 2023, may vote at the annual meeting or by proxy over the telephone, through the internet or using the Notice of Internet Availability of Proxy Materials mailed to such stockholders. Stockholders may change their vote at any time before the final vote at the annual meeting.</p> <p>Details regarding voting procedures are included in the Company’s proxy statement for the annual meeting, filed with the U.S. Securities and Exchange Commission on April 28, 2023.</p> <p><strong>About Bionano Genomics</strong></p> <p>Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, the Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit www.bionano.com, www.bionanolaboratories.com or www.biodiscovery.com.</p> <p><strong>Letter to Stockholders</strong></p> <p>May 1, 2023</p> <p>Re: <strong><u>Stockholder Action Letter: Request for Vote!</u></strong></p> <p>Dear Fellow Stockholders:</p> <p>I am writing to ask for your support on the proposals described in our 2023 Definitive Proxy Statement, filed with the SEC on April 28, 2023. In particular, I am asking you to vote FOR Proposal 4, the reverse split proposal. We believe that if the reverse split proposal is not approved, our ability to prudently raise capital may be compromised, our ability to attract and retain critical talent may be impacted, and our ability to act strategically with regard to the use of our equity in future opportunistic transactions may be constrained, among other things. Implementing a reverse split would provide the flexibility we need to use our common stock for business and/or financial purposes. Our reverse split proposal is a request to support a constructive tool that we believe is essential to achieving our long-term goals.</p> <p><strong>Bionano’s business has been progressing and still requires ongoing innovation and investment.</strong></p> <p>Bionano is focused on transforming traditional cytogenetic workflows into a modern, molecular workflow based on optical genome mapping (OGM). Current cytogenetic workflows are antiquated, slow and fail to provide useful results in roughly 50% of cases. Numerous published studies from laboratories and hospitals around the world have demonstrated that OGM has the potential to replace traditional cytogenetic methods, including fluorescence <em>in situ</em> hybridization (FISH), karyotyping, southern blot and chromosomal microarrays, with the OGM workflow as an alternative that is streamlined, yields useful results in substantially more samples, is less costly, and is simpler and faster. OGM has applications in cancer, genetic disease and cell bioprocessing quality control for drug development.</p> <p>We have made extraordinary progress since the summer of 2020, enabled by the advancements in market development and product development, and accelerated by the capital we raised in early 2021.</p> <ul><li><strong>Our annual revenue grew 227% between 2020 and 2022,</strong> from $8.5M in 2020, to $17.9M in 2021, to $27.8M in 2022</li><li><strong>The installed base of Saphyr® systems for OGM grew 147%</strong> <strong>between 2020 and 2022, </strong>from 97 as of the end of 2020, to 164 as of the end of 2021, to 240 as of the end of 2022</li><li><strong>Sales of nanochannel array flow cells grew substantially </strong>with 6,013 sold in 2020, 12,518 sold in 2021 and 15,375 sold in 2022</li><li><strong>Performance of our products has improved significantly</strong> since the launch of the Saphyr system in 2017, including a 13-fold increase in OGM throughput and a reduction in the price of analyzing a single genome from $1,500 to as low as $450</li><li><strong>Publications describing OGM in clinical research grew substantially</strong> from 23 as of the end of 2020, to 53 as of the end of 2021, to 108 as of the end of 2022 and the number of published clinical genomes using OGM grew from 214 in 2020, to 1,478 in 2021, to 3,092 at the end of 2022</li><li><strong>Our product portfolio in clinical services, which began with an acquisition in 2020, has expanded to include OGM-based laboratory developed tests (LDTs)</strong> for use in diagnosing a genetic disease known as facioscapulohumeral dystrophy (FSHD) and blood cancers such as different forms of leukemia</li><li><strong>Bionano has completed two acquisitions</strong> that we believe will enable delivery of a streamlined and simplified end-to-end workflow for OGM, a key requirement for routine use customers<br/></li></ul> <p>We believe the progress made in the preceding three years reflects the early adoption of OGM by clinical researchers seeking to adopt a new and novel method and demonstrate its utility. Going forward, our strategy for 2023 through 2025 is to continue that momentum and, among other things, achieve between a 30% to 50% compound annual growth rate for revenue. Our 2023 to 2025 strategy includes:</p> <ul><li><strong>Develop and launch significant new products</strong> <ul><li>Our next generation optical genome mapping system will have an increased throughput of approximately four times that of the current Saphyr system at launch and is expected to eventually reach a 13-fold increase in throughput</li><li>A version of our VIA™ software (currently named NxClinical™) which will integrate OGM data for data visualization, analysis and interpretation alongside next-generation sequencing (NGS) and other data types</li><li>A consumable and protocol for isolation of ultra-high molecular weight (UHMW) DNA for use with isotachophoresis (ITP) on the Ionic® system for automated nucleic acid isolation</li></ul> </li><li><strong>Continue developing the market for OGM and clearing the path for reimbursement</strong> of OGM through clinical research and seek FDA clearance to market OGM for clinical use <ul><li>Our clinical studies for genome analysis in pre-natal and post-natal conditions, blood cancers and solid-tumor cancers are expected to continue. We believe the volume of samples analyzed and published combined with health-economic analysis have the potential to result in OGM being included in professional societies’ guidelines for clinical testing.</li><li>We plan to submit an application for a local coverage decision (LCD) to Medicare for reimbursement coverage of OGM for hematologic malignancies.</li><li>We will begin preliminary pre-submission discussion with the FDA regarding clearance of OGM in 2023.</li></ul> </li><li><strong>Retaining and adding key talent</strong> to expand our commercial footprint globally, to develop new applications of OGM and to translate OGM into a technique that is used routinely throughout genome analysis<br/></li></ul> <p><strong>A vote FOR Proposal 4 would enable management to invest prudently in the business and to continue driving progress</strong></p> <p>We believe it is imperative for stockholders to authorize Bionano’s Board of Directors to effect a reverse split, as outlined in Proposal 4, to continue and potentially accelerate the momentum begun in 2020 and to deliver on the strategy outlined above. There are three primary outcomes of a reverse split that management believes are critical to realize:</p> <ul><li><strong>A reverse split would result in potential improvement in the marketability and liquidity of our common stock. </strong>We believe that a higher stock price would make our common stock more attractive to a broader range of institutional and other investors, which we believe would improve the marketability and liquidity of our common stock and increase interest and trading in our common stock, including by long-term institutional investors and funds who may not find our shares attractive at its current trading price.</li><li><strong>A reverse split would effectively increase the number of shares of common stock available to issue.</strong> A reverse split would decrease the number of shares of common stock outstanding but would not impact the number of our authorized shares of common stock. At this time, the current number of authorized and unreserved shares available for future issuance: (i) is insufficient to meet our anticipated future capital requirements through equity financings, including pursuant to our “at-the-market” sales agreement with Cowen and Company, LLC; (ii) is insufficient to provide future equity incentive opportunities, which may impact our ability to attract and retain the talent we believe is important to the success of the company; and (iii) may unduly constrain our ability to act strategically with regard to the use of our equity in future opportunistic transactions. Implementing a reverse split would provide the flexibility we need to use our common stock for business and/or financial purposes.</li><li><strong>A reverse split would support ongoing compliance with Nasdaq listing requirements</strong>. Our common stock is listed on the Nasdaq Capital Market, which has as one of its continued listing requirements a minimum bid price of at least $1.00 per share. The closing price of our common stock for the ten consecutive business days between April 17 and April 28 was below $1.00, reaching a low of $0.68 per share on April 21. If the closing price of our common stock remains below $1.00 for 30 consecutive business days, we would fall out of compliance with the minimum bid price requirement. If we were to fail to regain compliance, our common stock could be subject to delisting from the Nasdaq Capital Market, which may lead to a loss of confidence of our customers, collaborators, vendors and employees, which could do irreparable harm to our business and future prospects.<br/></li></ul> <p>In order to ensure that we can respect the voices of those who vote, we issued one share of Series A Preferred Stock to the Chairman of our Board of Directors. The share of Series A Preferred Stock has 3,000,000,000 votes, but those votes must be voted in the same proportion as the votes cast by our common stockholders and can only vote on Proposal 4. The votes of the preferred share would not change the voice of shareholders who vote but would simply mirror their votes so that in the event there are more than a majority of the votes cast in favor of Proposal 4, there should be enough votes to pass the proposal. The Series A Preferred Stock will be redeemed and retired automatically after approval of a reverse stock split proposal pursuant to its terms.</p> <p>For other companies, a request for authorization to effect a reverse split may reflect a sign of distress. We believe that the reverse split proposal is not a sign of distress for Bionano. Instead, it is a mechanism to enable management to prudently raise capital in support of our long-term strategy.</p> <p>Please support management by voting FOR all proxy proposals. Most importantly please support management by voting FOR Proposal 4.</p> <p>Sincerely,</p> <p>Erik Holmlin, PhD<br/>President and CEO<br/>Bionano Genomics, Inc.</p> <p><strong><em>Forward-Looking Statements</em></strong></p> <p><em>This letter contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “continue,” “could,” “expect,” “intend,” “may,” “plan,” “will,” “should” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify these forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: (1) the anticipated benefits of the reverse split, including on the marketability and liquidity of our common stock, our ability to execute on our long-term strategy and our compliance with Nasdaq listing requirements; (2) the utility of OGM for applications cancer, genetic disease and cell bioprocessing quality control, and its ability to complement or replace traditional cytogenomic methods for analysis of structural variations; (3) our anticipated goals and milestones for OGM and Bionano, including improved adoption of OGM, reimbursement of OGM through clinical research and FDA clearance to market OGM for clinical use; (4) our growth prospects and estimates regarding future financial performance and operating results; (5) our future products and features, including the performance of these products and their sample processing capacity; and (6) our anticipated growth strategies and anticipated trends in our business. Each of these forward-looking statements involves risks and uncertainties. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of geopolitical and macroeconomic developments, such as recent and potential future bank failures, the ongoing Ukraine-Russia conflict, related sanctions and the COVID-19 pandemic, on our business and the global economy; challenges inherent in developing, manufacturing and commercializing products; our ability to further deploy new products and applications and expand the markets for our technology platforms; third parties’ abilities to manufacture our instruments and consumables; our assumptions, expectations and beliefs regarding future growth of the business and the markets in which we operate; the completion and success of our clinical studies; the success of products competitive with our own; changes in our strategic and commercial plans; the application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions; study results that are different from or contradict the results presented in this letter; our assumptions and estimates regarding our future financial performance and results of operations; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2022 and in other filings subsequently made by us with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as required by law.</em></p> <p><strong>CONTACTS</strong></p> <p><strong>Company Contact:</strong><br/>Erik Holmlin, CEO<br/>Bionano Genomics, Inc.<br/>+1 (858) 888-7610<br/>eholmlin@bionano.com</p> <p><strong>Investor Relations:</strong><br/>David Holmes<br/>Gilmartin Group<br/>+1 (858) 888-7625<br/>IR@bionano.com</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/OWQ4OTgzNDctZTBhNy00YzlhLTkzOTAtNjcyMDg0ZWQ2NDk5LTUwMDA1MjUyMQ==/tiny/Bionano-Genomics.png\"/></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics","BK4199":"纸制品","ITP":"IT科技包装","BK4121":"生命科学工具和服务","BK4575":"芯片概念","BK4179":"石油天然气设备与服务","NGS":"Natural Gas Services Group Inc"},"source_url":"https://www.globenewswire.com/news-release/2023/05/01/2658702/0/en/Bionano-Announces-the-Publication-of-Stockholder-Letter-Regarding-Support-for-Proxy-Proposal.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2332985143","content_text":"SAN DIEGO, May  01, 2023  (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), today announced that on May 1, 2023, it published an open letter to stockholders in support of its proposals at its upcoming annual meeting of stockholders, a copy of which is included at the end of this press release.  Details of the Annual Meeting of Stockholders The annual meeting of stockholders will be held virtually, via live webcast at www.virtualshareholdermeeting.com/BNGO2023, on June 14, 2023, at 10:00 a.m. Pacific Time. Stockholders of record as of April 24, 2023, may vote at the annual meeting or by proxy over the telephone, through the internet or using the Notice of Internet Availability of Proxy Materials mailed to such stockholders. Stockholders may change their vote at any time before the final vote at the annual meeting. Details regarding voting procedures are included in the Company’s proxy statement for the annual meeting, filed with the U.S. Securities and Exchange Commission on April 28, 2023. About Bionano Genomics Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. Through its BioDiscovery business, the Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. For more information, visit www.bionano.com, www.bionanolaboratories.com or www.biodiscovery.com. Letter to Stockholders May 1, 2023 Re: Stockholder Action Letter: Request for Vote! Dear Fellow Stockholders: I am writing to ask for your support on the proposals described in our 2023 Definitive Proxy Statement, filed with the SEC on April 28, 2023. In particular, I am asking you to vote FOR Proposal 4, the reverse split proposal. We believe that if the reverse split proposal is not approved, our ability to prudently raise capital may be compromised, our ability to attract and retain critical talent may be impacted, and our ability to act strategically with regard to the use of our equity in future opportunistic transactions may be constrained, among other things. Implementing a reverse split would provide the flexibility we need to use our common stock for business and/or financial purposes. Our reverse split proposal is a request to support a constructive tool that we believe is essential to achieving our long-term goals. Bionano’s business has been progressing and still requires ongoing innovation and investment. Bionano is focused on transforming traditional cytogenetic workflows into a modern, molecular workflow based on optical genome mapping (OGM). Current cytogenetic workflows are antiquated, slow and fail to provide useful results in roughly 50% of cases. Numerous published studies from laboratories and hospitals around the world have demonstrated that OGM has the potential to replace traditional cytogenetic methods, including fluorescence in situ hybridization (FISH), karyotyping, southern blot and chromosomal microarrays, with the OGM workflow as an alternative that is streamlined, yields useful results in substantially more samples, is less costly, and is simpler and faster. OGM has applications in cancer, genetic disease and cell bioprocessing quality control for drug development. We have made extraordinary progress since the summer of 2020, enabled by the advancements in market development and product development, and accelerated by the capital we raised in early 2021. Our annual revenue grew 227% between 2020 and 2022, from $8.5M in 2020, to $17.9M in 2021, to $27.8M in 2022The installed base of Saphyr® systems for OGM grew 147% between 2020 and 2022, from 97 as of the end of 2020, to 164 as of the end of 2021, to 240 as of the end of 2022Sales of nanochannel array flow cells grew substantially with 6,013 sold in 2020, 12,518 sold in 2021 and 15,375 sold in 2022Performance of our products has improved significantly since the launch of the Saphyr system in 2017, including a 13-fold increase in OGM throughput and a reduction in the price of analyzing a single genome from $1,500 to as low as $450Publications describing OGM in clinical research grew substantially from 23 as of the end of 2020, to 53 as of the end of 2021, to 108 as of the end of 2022 and the number of published clinical genomes using OGM grew from 214 in 2020, to 1,478 in 2021, to 3,092 at the end of 2022Our product portfolio in clinical services, which began with an acquisition in 2020, has expanded to include OGM-based laboratory developed tests (LDTs) for use in diagnosing a genetic disease known as facioscapulohumeral dystrophy (FSHD) and blood cancers such as different forms of leukemiaBionano has completed two acquisitions that we believe will enable delivery of a streamlined and simplified end-to-end workflow for OGM, a key requirement for routine use customers We believe the progress made in the preceding three years reflects the early adoption of OGM by clinical researchers seeking to adopt a new and novel method and demonstrate its utility. Going forward, our strategy for 2023 through 2025 is to continue that momentum and, among other things, achieve between a 30% to 50% compound annual growth rate for revenue. Our 2023 to 2025 strategy includes: Develop and launch significant new products Our next generation optical genome mapping system will have an increased throughput of approximately four times that of the current Saphyr system at launch and is expected to eventually reach a 13-fold increase in throughputA version of our VIA™ software (currently named NxClinical™) which will integrate OGM data for data visualization, analysis and interpretation alongside next-generation sequencing (NGS) and other data typesA consumable and protocol for isolation of ultra-high molecular weight (UHMW) DNA for use with isotachophoresis (ITP) on the Ionic® system for automated nucleic acid isolation Continue developing the market for OGM and clearing the path for reimbursement of OGM through clinical research and seek FDA clearance to market OGM for clinical use Our clinical studies for genome analysis in pre-natal and post-natal conditions, blood cancers and solid-tumor cancers are expected to continue. We believe the volume of samples analyzed and published combined with health-economic analysis have the potential to result in OGM being included in professional societies’ guidelines for clinical testing.We plan to submit an application for a local coverage decision (LCD) to Medicare for reimbursement coverage of OGM for hematologic malignancies.We will begin preliminary pre-submission discussion with the FDA regarding clearance of OGM in 2023. Retaining and adding key talent to expand our commercial footprint globally, to develop new applications of OGM and to translate OGM into a technique that is used routinely throughout genome analysis A vote FOR Proposal 4 would enable management to invest prudently in the business and to continue driving progress We believe it is imperative for stockholders to authorize Bionano’s Board of Directors to effect a reverse split, as outlined in Proposal 4, to continue and potentially accelerate the momentum begun in 2020 and to deliver on the strategy outlined above. There are three primary outcomes of a reverse split that management believes are critical to realize: A reverse split would result in potential improvement in the marketability and liquidity of our common stock. We believe that a higher stock price would make our common stock more attractive to a broader range of institutional and other investors, which we believe would improve the marketability and liquidity of our common stock and increase interest and trading in our common stock, including by long-term institutional investors and funds who may not find our shares attractive at its current trading price.A reverse split would effectively increase the number of shares of common stock available to issue. A reverse split would decrease the number of shares of common stock outstanding but would not impact the number of our authorized shares of common stock. At this time, the current number of authorized and unreserved shares available for future issuance: (i) is insufficient to meet our anticipated future capital requirements through equity financings, including pursuant to our “at-the-market” sales agreement with Cowen and Company, LLC; (ii) is insufficient to provide future equity incentive opportunities, which may impact our ability to attract and retain the talent we believe is important to the success of the company; and (iii) may unduly constrain our ability to act strategically with regard to the use of our equity in future opportunistic transactions. Implementing a reverse split would provide the flexibility we need to use our common stock for business and/or financial purposes.A reverse split would support ongoing compliance with Nasdaq listing requirements. Our common stock is listed on the Nasdaq Capital Market, which has as one of its continued listing requirements a minimum bid price of at least $1.00 per share. The closing price of our common stock for the ten consecutive business days between April 17 and April 28 was below $1.00, reaching a low of $0.68 per share on April 21. If the closing price of our common stock remains below $1.00 for 30 consecutive business days, we would fall out of compliance with the minimum bid price requirement. If we were to fail to regain compliance, our common stock could be subject to delisting from the Nasdaq Capital Market, which may lead to a loss of confidence of our customers, collaborators, vendors and employees, which could do irreparable harm to our business and future prospects. In order to ensure that we can respect the voices of those who vote, we issued one share of Series A Preferred Stock to the Chairman of our Board of Directors. The share of Series A Preferred Stock has 3,000,000,000 votes, but those votes must be voted in the same proportion as the votes cast by our common stockholders and can only vote on Proposal 4. The votes of the preferred share would not change the voice of shareholders who vote but would simply mirror their votes so that in the event there are more than a majority of the votes cast in favor of Proposal 4, there should be enough votes to pass the proposal. The Series A Preferred Stock will be redeemed and retired automatically after approval of a reverse stock split proposal pursuant to its terms. For other companies, a request for authorization to effect a reverse split may reflect a sign of distress. We believe that the reverse split proposal is not a sign of distress for Bionano. Instead, it is a mechanism to enable management to prudently raise capital in support of our long-term strategy. Please support management by voting FOR all proxy proposals. Most importantly please support management by voting FOR Proposal 4. Sincerely, Erik Holmlin, PhDPresident and CEOBionano Genomics, Inc. Forward-Looking Statements This letter contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “continue,” “could,” “expect,” “intend,” “may,” “plan,” “will,” “should” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) convey uncertainty of future events or outcomes and are intended to identify these forward-looking statements. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: (1) the anticipated benefits of the reverse split, including on the marketability and liquidity of our common stock, our ability to execute on our long-term strategy and our compliance with Nasdaq listing requirements; (2) the utility of OGM for applications cancer, genetic disease and cell bioprocessing quality control, and its ability to complement or replace traditional cytogenomic methods for analysis of structural variations; (3) our anticipated goals and milestones for OGM and Bionano, including improved adoption of OGM, reimbursement of OGM through clinical research and FDA clearance to market OGM for clinical use; (4) our growth prospects and estimates regarding future financial performance and operating results; (5) our future products and features, including the performance of these products and their sample processing capacity; and (6) our anticipated growth strategies and anticipated trends in our business. Each of these forward-looking statements involves risks and uncertainties. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include the risks and uncertainties associated with: the impact of geopolitical and macroeconomic developments, such as recent and potential future bank failures, the ongoing Ukraine-Russia conflict, related sanctions and the COVID-19 pandemic, on our business and the global economy; challenges inherent in developing, manufacturing and commercializing products; our ability to further deploy new products and applications and expand the markets for our technology platforms; third parties’ abilities to manufacture our instruments and consumables; our assumptions, expectations and beliefs regarding future growth of the business and the markets in which we operate; the completion and success of our clinical studies; the success of products competitive with our own; changes in our strategic and commercial plans; the application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions; study results that are different from or contradict the results presented in this letter; our assumptions and estimates regarding our future financial performance and results of operations; our ability to obtain sufficient financing to fund our strategic plans and commercialization efforts; and the risks and uncertainties associated with our business and financial condition in general, including the risks and uncertainties described in our filings with the Securities and Exchange Commission, including, without limitation, our Annual Report on Form 10-K for the year ended December 31, 2022 and in other filings subsequently made by us with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise, except as required by law. CONTACTS Company Contact:Erik Holmlin, CEOBionano Genomics, Inc.+1 (858) 888-7610eholmlin@bionano.com Investor Relations:David HolmesGilmartin Group+1 (858) 888-7625IR@bionano.com","news_type":1,"symbols_score_info":{"NGS":1,"BNGO":1,"ITP":1}},"isVote":1,"tweetType":1,"viewCount":2376,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943793366,"gmtCreate":1679676439956,"gmtModify":1679676443633,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"thieves","listText":"thieves","text":"thieves","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943793366","repostId":"9943489221","repostType":1,"repost":{"id":9943489221,"gmtCreate":1679631350764,"gmtModify":1679631370310,"author":{"id":"3527667621665671","authorId":"3527667621665671","name":"Daily_Discussion","avatar":"https://community-static.tradeup.com/news/6973ef3354e752778088dfd8ca725c82","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667621665671","idStr":"3527667621665671"},"themes":[],"title":"🚀Share your strategy for making money on the market！(24 Mar)","htmlText":"Hi, Tigers!Welcome to&nbsp;Daily Discussion&nbsp;! This is the place for you to share your trading ideas and win coins!<a href=\"https://ttm.financial/RN?name=RNTheme&amp;page=/theme/special/discussion&amp;rndata={&quot;themeId&quot;:&quot;470d3ab575ca43caaed8156645b7ccbe&quot;,&quot;type&quot;:3}\" target=\"_blank\">Join the conversation by sharing your thoughts.</a>[Rewards]1.&nbsp;We will reward you with50 Tiger Coins&nbsp;when you share your knowledge about stocks and markets on here, depending onquality and originality.(NOTE: Comments posted under this article WILL NOT be counted)2.&nbsp;You will be given5 Tiger coins&nbsp;if you tag more than 3 friends in the comment areaMeanwhile, we will be listing the stocks mentioned by those selected Tigers for your reference every day (not invest","listText":"Hi, Tigers!Welcome to&nbsp;Daily Discussion&nbsp;! This is the place for you to share your trading ideas and win coins!<a href=\"https://ttm.financial/RN?name=RNTheme&amp;page=/theme/special/discussion&amp;rndata={&quot;themeId&quot;:&quot;470d3ab575ca43caaed8156645b7ccbe&quot;,&quot;type&quot;:3}\" target=\"_blank\">Join the conversation by sharing your thoughts.</a>[Rewards]1.&nbsp;We will reward you with50 Tiger Coins&nbsp;when you share your knowledge about stocks and markets on here, depending onquality and originality.(NOTE: Comments posted under this article WILL NOT be counted)2.&nbsp;You will be given5 Tiger coins&nbsp;if you tag more than 3 friends in the comment areaMeanwhile, we will be listing the stocks mentioned by those selected Tigers for your reference every day (not invest","text":"Hi, Tigers!Welcome to Daily Discussion ! This is the place for you to share your trading ideas and win coins!Join the conversation by sharing your thoughts.[Rewards]1. We will reward you with50 Tiger Coins when you share your knowledge about stocks and markets on here, depending onquality and originality.(NOTE: Comments posted under this article WILL NOT be counted)2. You will be given5 Tiger coins if you tag more than 3 friends in the comment areaMeanwhile, we will be listing the stocks mentioned by those selected Tigers for your reference every day (not invest","images":[{"img":"https://community-static.tradeup.com/news/2bfd9d59aee3e0d471db6db80aeab3ed","width":"-1","height":"-1"},{"img":"https://community-static.tradeup.com/news/48c22e2b78d9ab6ca9791b90e628729c","width":"-1","height":"-1"},{"img":"https://community-static.tradeup.com/news/398cc575d7f445d44a155e261f82e067","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943489221","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":992,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943793023,"gmtCreate":1679676347262,"gmtModify":1679676354352,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Ha ha.... manipulation..&nbsp; &nbsp;almost I write true!","listText":"Ha ha.... manipulation..&nbsp; &nbsp;almost I write true!","text":"Ha ha.... manipulation.. almost I write true!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943793023","repostId":"2321367199","repostType":2,"repost":{"id":"2321367199","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1679652203,"share":"https://ttm.financial/m/news/2321367199?lang=en_US&edition=fundamental","pubTime":"2023-03-24 18:03","market":"us","language":"en","title":"BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2321367199","media":"Reuters","summary":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK","content":"<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-03-24 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","BK4082":"医疗保健设备","BK4196":"保健护理服务","ONTF":"ON24, Inc.","SANA":"Sana Biotechnology, Inc.","ALLR":"Allarity Therapeutics Inc","LABP":"Landos Biopharma, Inc.","BK4007":"制药","LHDX":"Lucira Health, Inc.","CGEM":"Cullinan Therapeutics","BK4023":"应用软件"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2321367199","content_text":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARESSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"APR":0.9,"CGEM":0.9,"SANA":0.9,"LABP":0.9,"ALLR":0.9,"LHDX":0.9,"016744203":0.9,"ONTF":0.9}},"isVote":1,"tweetType":1,"viewCount":772,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943454169,"gmtCreate":1679655891751,"gmtModify":1679655896773,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Thank you very much,you are angels!Just make price 0.05 and split in 35 . Awesome![Cool]&nbsp;","listText":"Thank you very much,you are angels!Just make price 0.05 and split in 35 . Awesome![Cool]&nbsp;","text":"Thank you very much,you are angels!Just make price 0.05 and split in 35 . Awesome![Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943454169","repostId":"2321367199","repostType":2,"repost":{"id":"2321367199","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1679652203,"share":"https://ttm.financial/m/news/2321367199?lang=en_US&edition=fundamental","pubTime":"2023-03-24 18:03","market":"us","language":"en","title":"BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2321367199","media":"Reuters","summary":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK","content":"<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-03-24 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4139":"生物科技","BK4082":"医疗保健设备","BK4196":"保健护理服务","ONTF":"ON24, Inc.","SANA":"Sana Biotechnology, Inc.","ALLR":"Allarity Therapeutics Inc","LABP":"Landos Biopharma, Inc.","BK4007":"制药","LHDX":"Lucira Health, Inc.","CGEM":"Cullinan Therapeutics","BK4023":"应用软件"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2321367199","content_text":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARESSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"APR":0.9,"CGEM":0.9,"SANA":0.9,"LABP":0.9,"ALLR":0.9,"LHDX":0.9,"016744203":0.9,"ONTF":0.9}},"isVote":1,"tweetType":1,"viewCount":958,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943614189,"gmtCreate":1679405876342,"gmtModify":1679406880764,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Some buy shares at $3 each, after which the company goes bankrupt.....what idiot can buy at such a price without knowing the purpose? There is manipulation going on.","listText":"Some buy shares at $3 each, after which the company goes bankrupt.....what idiot can buy at such a price without knowing the purpose? There is manipulation going on.","text":"Some buy shares at $3 each, after which the company goes bankrupt.....what idiot can buy at such a price without knowing the purpose? There is manipulation going on.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943614189","repostId":"2321515416","repostType":2,"repost":{"id":"2321515416","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1679334180,"share":"https://ttm.financial/m/news/2321515416?lang=en_US&edition=fundamental","pubTime":"2023-03-21 01:43","market":"hk","language":"en","title":"Boxed Up 42% to 14 Cents Following Three Days of Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2321515416","media":"Dow Jones","summary":"By Josh Beckerman \n\n\n \n\n\nBoxed Inc. shares, which posted three consecutive double-digit declines aft","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/BOXD\">Boxed Inc</a>. shares, which posted three consecutive double-digit declines after the e-commerce company said it was considering a bankruptcy filing, rose 42% to 14 cents on Monday. \n</p>\n<p>\n  Volume was more than 37.4 million shares, compared with a 65-day average of 3.69 million. \n</p>\n<p>\n  On Friday, Boxed said it wouldn't file its Form 10-K on time as it continued to work on negotiating a forbearance agreement, exploring strategic alternatives and restructuring financing arrangements. \n</p>\n<p>\n  Boxed expects a 2022 net loss of about $115 million. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 20, 2023 13:43 ET (17:43 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boxed Up 42% to 14 Cents Following Three Days of Declines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoxed Up 42% to 14 Cents Following Three Days of Declines\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2023-03-21 01:43</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Josh Beckerman \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/BOXD\">Boxed Inc</a>. shares, which posted three consecutive double-digit declines after the e-commerce company said it was considering a bankruptcy filing, rose 42% to 14 cents on Monday. \n</p>\n<p>\n  Volume was more than 37.4 million shares, compared with a 65-day average of 3.69 million. \n</p>\n<p>\n  On Friday, Boxed said it wouldn't file its Form 10-K on time as it continued to work on negotiating a forbearance agreement, exploring strategic alternatives and restructuring financing arrangements. \n</p>\n<p>\n  Boxed expects a 2022 net loss of about $115 million. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 20, 2023 13:43 ET (17:43 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4122":"互联网与直销零售","BK4007":"制药","BK4191":"家用电器","TERN":"Terns Pharmaceuticals, Inc.","BOXD":"Boxed Inc","BK4539":"次新股","CRCT":"Cricut, Inc."},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2321515416","content_text":"By Josh Beckerman \n\n\n \n\n\nBoxed Inc. shares, which posted three consecutive double-digit declines after the e-commerce company said it was considering a bankruptcy filing, rose 42% to 14 cents on Monday. \n\n\n  Volume was more than 37.4 million shares, compared with a 65-day average of 3.69 million. \n\n\n  On Friday, Boxed said it wouldn't file its Form 10-K on time as it continued to work on negotiating a forbearance agreement, exploring strategic alternatives and restructuring financing arrangements. \n\n\n  Boxed expects a 2022 net loss of about $115 million. \n\n\n \n\n\n  Write to Josh Beckerman at josh.beckerman@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 20, 2023 13:43 ET (17:43 GMT)\n\n\n  Copyright (c) 2023 Dow Jones & Company, Inc.","news_type":1,"symbols_score_info":{"TERN":0.83,"BOXD":0.9,"CRCT":0.83}},"isVote":1,"tweetType":1,"viewCount":949,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9949470287,"gmtCreate":1678859286550,"gmtModify":1678859291449,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Nio is pain.....scrabb","listText":"Nio is pain.....scrabb","text":"Nio is pain.....scrabb","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949470287","repostId":"2319866747","repostType":2,"repost":{"id":"2319866747","kind":"highlight","pubTimestamp":1678858713,"share":"https://ttm.financial/m/news/2319866747?lang=en_US&edition=fundamental","pubTime":"2023-03-15 13:38","market":"us","language":"en","title":"Nio Won't Get Involved In Price War, Exec Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2319866747","media":"CnEVPost","summary":"China's auto industry is facing cyclical swings in the transition to electrification that can't be weathered by price wars and require automakers to stick to brand values, an NIO e\n...","content":"<div>\n<p>China's auto industry is facing cyclical swings in the transition to electrification that can't be weathered by price wars and require automakers to stick to brand values, an NIO executive said.An NIO...</p>\n\n<a href=\"https://cnevpost.com/2023/03/14/nio-wont-get-involved-in-price-war-exec-says/\">Source Link</a>\n\n</div>\n","source":"cnevpost_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nio Won't Get Involved In Price War, Exec Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNio Won't Get Involved In Price War, Exec Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-15 13:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://cnevpost.com/2023/03/14/nio-wont-get-involved-in-price-war-exec-says/><strong>CnEVPost</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>China's auto industry is facing cyclical swings in the transition to electrification that can't be weathered by price wars and require automakers to stick to brand values, an NIO executive said.An NIO...</p>\n\n<a href=\"https://cnevpost.com/2023/03/14/nio-wont-get-involved-in-price-war-exec-says/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO.SI":"蔚来","09866":"蔚来-SW","NIO":"蔚来"},"source_url":"https://cnevpost.com/2023/03/14/nio-wont-get-involved-in-price-war-exec-says/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2319866747","content_text":"China's auto industry is facing cyclical swings in the transition to electrification that can't be weathered by price wars and require automakers to stick to brand values, an NIO executive said.An NIO executive said the company won't get involved in a price war, which has come into focus with the recent sharp price cuts by a large number of internal combustion engine (ICE) automakers.NIO will not engage in a price war and will not respond to the current market volatility with price cuts, said Pu Yang, the company's assistant vice president of sales operations, at a media briefing today.NIO believes that the current wave of price cuts is a cyclical fluctuation in the transition from ICE vehicles to smart electric vehicles (EVs), with the main players being ICE models from joint venture brands with limited competitiveness, Pu said, according to minutes shared by several automotive bloggers.The cyclical fluctuations brought about by this technological revolution can't be crossed by price wars and require car companies to stick to their brand values, he said.NIO will always ensure the user experience and cope with this cycle by efforts including continuous investment in infrastructure, keeping prices and configurations stable, and full-stack in-house research and development, he said.More and more car companies are joining the price war, leading to an increased wait-and-see sentiment among consumers to avoid seeing price cuts soon after purchasing a car.NIO's local counterpart, Li Auto (NASDAQ: LI), has introduced a consumer price-protection benefit that will refund the difference if the price drops within 90 days of their purchase.Pu said he saw Li Auto's move and that NIO had considered whether to issue a similar policy, but for the company, it had previously made it clear that prices would not go down.Not only is NIO not dropping prices for 90 days, but prices won't change for a longer period of time, he said.He believes the current plunge in ICE vehicle prices in China will be a landmark event and potentially a watershed moment for the auto industry as a whole.Many of the products that have seen significant price cuts are at the end of their life cycle, Pu said, adding that he doesn't think that will be the norm.He believes that the large number of models that have seen significant price cuts are appearing quickly, and that these moves will disappear quickly, and that this will be some sort of catalyst for the development of the new energy vehicle (NEV) market.Pu is optimistic about the whole-year performance of the passenger car market in China, and believes that sales will increase compared to last year.He mentioned that NIO has seen an increase in the number of visitors to its stores and test drives in recent times, and is confident of growth given the new products the company will have available and the upcoming Shanghai auto show.The NIO brand will not make prices lower by introducing single-motor models or models without LiDARs, Pu said, reiterating remarks made by William Li, the company's founder, chairman and CEO, during an earnings call earlier this month.Lower configurations and lower prices are not how NIO wins. The company started from the beginning with a desire to give users a highly configurable, high-quality-of-service experience, he said.Pu said he suggested to the company's management at the time of the ET5's launch that it could lower the barrier to purchase by eliminating the free battery swap benefit, but that was vetoed by Li.The ET5 is a good value when compared to competitors in the same price range as it, especially in terms of intelligence and performance, he said.NIO believes that improving service quality will be an effective means of dealing with the competition, including adding 1,000 new battery swap stations this year, he said.The penetration rate of NEVs in China will be higher this year, and the total market segment of high-end EVs will be larger, so NIO is expected to achieve better growth, Pu said.New products will be an important card for NIO this year, as the company will have more core products on the market this year and delivery is expected to be smoother, he said.As for the lower-priced EV market, NIO will cover it through sub-brands, including one codenamed ALPS, he said.","news_type":1,"symbols_score_info":{"NIO.SI":0.6,"NIO":1,"09866":0.6}},"isVote":1,"tweetType":1,"viewCount":1092,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9949327238,"gmtCreate":1678380733624,"gmtModify":1678380739479,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Need read 2 days....[Spurting]&nbsp;","listText":"Need read 2 days....[Spurting]&nbsp;","text":"Need read 2 days....[Spurting]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949327238","repostId":"2318256134","repostType":2,"isVote":1,"tweetType":1,"viewCount":908,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9949393931,"gmtCreate":1678343895023,"gmtModify":1678343898940,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949393931","repostId":"2318787232","repostType":4,"repost":{"id":"2318787232","kind":"news","pubTimestamp":1678332053,"share":"https://ttm.financial/m/news/2318787232?lang=en_US&edition=fundamental","pubTime":"2023-03-09 11:20","market":"us","language":"en","title":"Eberly Emerges as Frontrunner to Be Biden’s Fed Vice Chair Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=2318787232","media":"Bloomberg","summary":"Northwestern professor seen as a dovish voice, analyst saysA final decision has not yet been made, p","content":"<div>\n<p>Northwestern professor seen as a dovish voice, analyst saysA final decision has not yet been made, people familiar sayJanice Eberly  Photographer: David Paul Morris/BloombergNorthwestern University ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2023-03-09/eberly-emerges-as-frontrunner-to-be-biden-s-fed-vice-chair-pick?srnd=premium\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eberly Emerges as Frontrunner to Be Biden’s Fed Vice Chair Pick</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEberly Emerges as Frontrunner to Be Biden’s Fed Vice Chair Pick\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-09 11:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2023-03-09/eberly-emerges-as-frontrunner-to-be-biden-s-fed-vice-chair-pick?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Northwestern professor seen as a dovish voice, analyst saysA final decision has not yet been made, people familiar sayJanice Eberly  Photographer: David Paul Morris/BloombergNorthwestern University ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2023-03-09/eberly-emerges-as-frontrunner-to-be-biden-s-fed-vice-chair-pick?srnd=premium\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.bloomberg.com/news/articles/2023-03-09/eberly-emerges-as-frontrunner-to-be-biden-s-fed-vice-chair-pick?srnd=premium","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2318787232","content_text":"Northwestern professor seen as a dovish voice, analyst saysA final decision has not yet been made, people familiar sayJanice Eberly  Photographer: David Paul Morris/BloombergNorthwestern University Professor Janice Eberly is the frontrunner in the White House search for a successor to Lael Brainard as vice chair of the Federal Reserve, people familiar with the matter said.Eberly, who served as chief economist at the Treasury Department under President Barack Obama, has emerged quickly as a candidate in the weeks since Brainard was picked as President Joe Biden’s top economic aide.Eberly met recently for an interview with Jeff Zients, Biden’s chief of staff, as well as with Brainard and Treasury Secretary Janet Yellen, a former Fed chair, one of the people said. A final decision has not yet been made, the people said.One of the people said things are moving in her direction but Biden has yet to interview her.The White House did not immediately respond to a request for comment on Wednesday night.The Biden administration has indicated that it wants to fill the crucial position relatively soon, as the US central bank continues its aggressive campaign to quell inflation and opens the door to further, faster rate increases. Biden’s nominee must be confirmed by the US Senate, where Democrats hold a slim majority.White House Press Secretary Karine Jean-Pierre said Monday that the White House would announce developments “in the near future.”Some progressives are urging the White House to fill the vacancy with someone who would do more to defend the Fed’s mandate to support the labor market, and be less likely to push for further interest-rate hikes they warn could derail the economy.The Fed has raised rates from near zero a year ago to a range of 4.5% to 4.75% to try to cool persistent price pressures. Chair Jerome Powell told lawmakers this week rates are likely tomove higherand potentially faster than officials previously expected if economic data keeps coming in hot.Bharat Ramamurti, deputy director of the White House National Economic Council, told Bloomberg Television this week that the administration wants to “find somebody who truly believes in the Fed’s dual mandate, somebody who believes in the president’s economic vision.”Biden has also been urged to choose a Latino candidate to succeed Brainard, with 34 lawmakers signing a letter calling for such a trailblazing appointment.Eberly, if nominated, could run into opposition from lawmakers who have pushed for more diversity among the Fed’s upper ranks, testing Biden’s support in the Senate.Other names that have been in the mix for the role include Harvard University professor Karen Dynan, who along with Eberly was seen as a leading candidate for the position.While Dynan also held a key role in the Obama administration, succeeding Eberly as chief economist at the Treasury, Eberly is seen as the more dovish of the two, Bloomberg Chief US Economist Anna Wong wrote in a research analysis.Dynan would be one of the Fed’s most hawkish voices, Wong projected. “Eberly, on the other hand, might be closer to Brainard in her optimism that the Fed can get inflation back to target without generating a significant slowdown in the labor market,” Wong wrote.","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":1063,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9955488532,"gmtCreate":1675673542626,"gmtModify":1675673546202,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":25,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955488532","repostId":"2308854213","repostType":4,"repost":{"id":"2308854213","kind":"highlight","pubTimestamp":1675697292,"share":"https://ttm.financial/m/news/2308854213?lang=en_US&edition=fundamental","pubTime":"2023-02-06 23:28","market":"us","language":"en","title":"2 AI-Powered Growth Stocks to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2308854213","media":"Motley Fool","summary":"Artificial intelligence will shape the world's future; your portfolio should have some exposure to reflect that.","content":"<div>\n<p>Artificial intelligence (AI) is a fascinating technology whose potential hasn't been fully discovered. Incredible programs like ChatGPT have already passed the bar and U.S. medical licensing exam, but...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/2-artificial-intelligence-powered-growth-stocks-to/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 AI-Powered Growth Stocks to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 AI-Powered Growth Stocks to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-06 23:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/03/2-artificial-intelligence-powered-growth-stocks-to/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Artificial intelligence (AI) is a fascinating technology whose potential hasn't been fully discovered. Incredible programs like ChatGPT have already passed the bar and U.S. medical licensing exam, but...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/03/2-artificial-intelligence-powered-growth-stocks-to/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc.","CRWD":"CrowdStrike Holdings, Inc."},"source_url":"https://www.fool.com/investing/2023/02/03/2-artificial-intelligence-powered-growth-stocks-to/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2308854213","content_text":"Artificial intelligence (AI) is a fascinating technology whose potential hasn't been fully discovered. Incredible programs like ChatGPT have already passed the bar and U.S. medical licensing exam, but other, more practical uses of AI are already available for businesses to utilize.Two companies that utilize AI at the core of their software are CrowdStrike and Palantir. Each stock has a huge runway, and investors should consider these two stocks to fill out the AI investment niche in their portfolio. Read on to find out why.1. CrowdStrikeCrowdStrike utilizes AI to improve its cybersecurity software continuously. By analyzing trillions of signals weekly, CrowdStrike harnesses AI's power in a machine learning model to determine what activity is normal, an anomaly, or a threat. When one customer is attacked, it uses that information to improve the protection of all CrowdStrike clients, preventing an attacker from exploiting the same weakness twice.The solution is prevalent, with 21,146 clients as of Oct. 31, 2022, up 44% over last year's total. Among its customers are 40 U.S. state governments, 69 of the Fortune 500, and 15 of the top 20 U.S. banks. That's an impressive client list, but CrowdStrike's future growth depends on those customers expanding their usage.CrowdStrike has over 20 modules that expand the base offering and empower security teams to both improve the platform and gain greater visibility into the threats a client faces. The more modules the average customer uses, the more revenue CrowdStrike brings in, and it has been quite successful in upselling its product to its customers.Number of Modules UtilizedPercent of Customer BaseYOY Increase5 or More60%55%6 or More36%66%7 or More21%81%Source: CrowdStrike.New customers and existing client expansion helped increase CrowdStrike's annual recurring revenue by 54% to $2.34 billion in the third quarter of fiscal year 2023 (ended Oct. 31). It's also a free cash flow (FCF)-generating machine, converting 30% of Q3 revenue into FCF of $174 million.For the growth CrowdStrike is generating, its current price tag of 43 times FCF is a bargain -- that's only a 35% premium to Microsoft despite growing at a much faster pace. CrowdStrike is just in the early innings of its product deployment and is one of the best ways to invest in AI.2. PalantirPalantir utilizes AI in its software to crunch data and provide actionable insights. At first, its technology was developed for government use and reportedly helped the U.S. government pinpoint the final hideout of Osama bin Laden. Now, Palantir is rolling out its software for civilian use and is on a mission to help streamline a company's operations.As a testament to Palantir's usefulness, Tyson Foods realized about $200 million in cost savings across 20 different projects, and Swiss Re claimed Palantir's first $100 million or greater savings. As for new customers, Cloudflare recently signed a strategic partnership with Palantir to improve the costs associated with Cloudflare's cloud infrastructure offering.With only 228 commercial customers as of Sept. 30, investors might wonder why so few companies are using it. The answer lies in the cost -- a one-month subscription on the Amazon Web Services (AWS) store is $1 million per month. Because of its price tag, Palantir limits which customers can feasibly use its product to only the largest companies. However, that's still a sizable client base.It's also growing rapidly, with revenue up 22% year over year to $478 million. But U.S. commercial revenue (a key business focus) was up 53% in Q3. Unlike CrowdStrike, Palantir has a ways to go in its profitability department. FCF was $32.6 million for Q3 -- a 6.8% margin.Actual profits are even further off, with Palantir losing $124 million -- a 26% profit loss margin. Much of this loss is due to a high stock-based compensation bill of $140 million, although this was drastically down from 2021's Q3 value of $185 million. If investors take a position in Palantir, they will need to watch this trend to ensure it continues moving in the right direction, as Palantir has a lot of work to do before breaking even.With Palantir's current price-to-sales (P/S) ratio, it's pretty clear the market is skeptical about any profits.PLTR PS Ratio data by YCharts.At its current valuation, Palantir is worth taking a shot at, especially considering its powerful AI software. However, you'll have to be patient because it may take a while for profits to come to fruition.","news_type":1,"symbols_score_info":{"PLTR":0.9,"CRWD":0.9}},"isVote":1,"tweetType":1,"viewCount":436,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9957090894,"gmtCreate":1676705398719,"gmtModify":1676705402806,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":23,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957090894","repostId":"1100725481","repostType":4,"repost":{"id":"1100725481","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1676779312,"share":"https://ttm.financial/m/news/1100725481?lang=en_US&edition=fundamental","pubTime":"2023-02-19 12:01","market":"us","language":"en","title":"Reminder: U.S. Market Will Be Closed for Washington's Birthday on Monday, Feb. 20, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=1100725481","media":"Tiger Newspress","summary":"Washington's Birthday (Presidents Day) is around the corner. The U.S. market will be closed on Monda","content":"<html><head></head><body><p>Washington&#39;s Birthday (Presidents Day) is around the corner. The U.S. market will be closed on Monday, February 20, 2023. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.</p><p><b>About Presidents&#39; Day</b></p><p><b>Presidents&#39; Day</b>, also called <b>Washington&#39;s Birthday</b> at the federal governmental level, is a holiday in the United States celebrated on the third Monday of February to honor all people who served as presidents of the United States and, since 1879, has been the federal holiday honoring George Washington, who led the Continental Army to victory in the American Revolutionary War, presided at the Constitutional Convention of 1787, and was the first U.S. president.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9f9465ca4610b5c38f13638edda32b36\" tg-width=\"1024\" tg-height=\"576\" referrerpolicy=\"no-referrer\"/><span>George Washington with Flag</span></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reminder: U.S. Market Will Be Closed for Washington's Birthday on Monday, Feb. 20, 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReminder: U.S. Market Will Be Closed for Washington's Birthday on Monday, Feb. 20, 2023\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2023-02-19 12:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Washington&#39;s Birthday (Presidents Day) is around the corner. The U.S. market will be closed on Monday, February 20, 2023. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.</p><p><b>About Presidents&#39; Day</b></p><p><b>Presidents&#39; Day</b>, also called <b>Washington&#39;s Birthday</b> at the federal governmental level, is a holiday in the United States celebrated on the third Monday of February to honor all people who served as presidents of the United States and, since 1879, has been the federal holiday honoring George Washington, who led the Continental Army to victory in the American Revolutionary War, presided at the Constitutional Convention of 1787, and was the first U.S. president.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9f9465ca4610b5c38f13638edda32b36\" tg-width=\"1024\" tg-height=\"576\" referrerpolicy=\"no-referrer\"/><span>George Washington with Flag</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100725481","content_text":"Washington's Birthday (Presidents Day) is around the corner. The U.S. market will be closed on Monday, February 20, 2023. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.About Presidents' DayPresidents' Day, also called Washington's Birthday at the federal governmental level, is a holiday in the United States celebrated on the third Monday of February to honor all people who served as presidents of the United States and, since 1879, has been the federal holiday honoring George Washington, who led the Continental Army to victory in the American Revolutionary War, presided at the Constitutional Convention of 1787, and was the first U.S. president.George Washington with Flag","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":206402351644776,"gmtCreate":1691400722071,"gmtModify":1691400725173,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Thieves","listText":"Thieves","text":"Thieves","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/206402351644776","repostId":"2357463377","repostType":2,"isVote":1,"tweetType":1,"viewCount":3178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":202109998841904,"gmtCreate":1690349849449,"gmtModify":1690349852467,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/202109998841904","repostId":"2354337617","repostType":2,"isVote":1,"tweetType":1,"viewCount":3233,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9970060341,"gmtCreate":1683723421384,"gmtModify":1683723424832,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Thieves","listText":"Thieves","text":"Thieves","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9970060341","repostId":"2334220259","repostType":2,"isVote":1,"tweetType":1,"viewCount":2408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9940160267,"gmtCreate":1677755889460,"gmtModify":1677755893266,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Oke","listText":"Oke","text":"Oke","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":20,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9940160267","repostId":"2316618792","repostType":4,"repost":{"id":"2316618792","kind":"highlight","pubTimestamp":1677771117,"share":"https://ttm.financial/m/news/2316618792?lang=en_US&edition=fundamental","pubTime":"2023-03-02 23:31","market":"us","language":"en","title":"2 Stocks Down 55% and 71% to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2316618792","media":"Motley Fool","summary":"The bear market has created some rock-solid bargains. Here are two you should take advantage of.","content":"<div>\n<p>The stock market got off to a solid start in 2023, with the S&P 500 up nearly 4% (after being up as much as 9% early last month).Even with the good start, many individual stocks are still deep in bear...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/01/stocks-down-to-buy-right-now-3m-carparts/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Stocks Down 55% and 71% to Buy Right Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Stocks Down 55% and 71% to Buy Right Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-02 23:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/01/stocks-down-to-buy-right-now-3m-carparts/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market got off to a solid start in 2023, with the S&P 500 up nearly 4% (after being up as much as 9% early last month).Even with the good start, many individual stocks are still deep in bear...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/01/stocks-down-to-buy-right-now-3m-carparts/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MMM":"3M","PRTS":"CarParts"},"source_url":"https://www.fool.com/investing/2023/03/01/stocks-down-to-buy-right-now-3m-carparts/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2316618792","content_text":"The stock market got off to a solid start in 2023, with the S&P 500 up nearly 4% (after being up as much as 9% early last month).Even with the good start, many individual stocks are still deep in bear market territory, and the Federal Reserve continues to telegraph its intention to keep raising interest rates, which seems even likelier after strong January employment and retail sales reports and a hotter-than-expected personal consumption expenditures reading, which is the Fed's favorite inflation gauge.The good news is that the pressure from rising interest rates and the prospects of a recession are making a lot of quality stocks cheap. Two Motley Fool contributors were asked to explain why 3M and CarParts.com, which are trading down 55% and 71%, respectively, from recent highs, both look like buys right now.Beyond some short-term legal risks, there is good value in 3M stockParkev Tatevosian: Trading down 55% off its high in 2019, now might be an excellent time for investors to consider 3M stock. The 121-year-old company profitably manufactures a diverse assortment of products that give it a presence across multiple industries and in several countries. While the troubled economy has had some effect on the stock price, much of the reason for its current reasonable valuation lies in concerns about its fiscal exposure to multiple lawsuits it is facing.Over decades, 3M has established itself in categories critical to enterprises and consumers. That's put it in a position to consistently deliver revenue topping $30 billion annually. More impressively, 3M has improved efficiencies in its business to expand its earnings per share from $6.72 in 2013 to $10.18 in 2022. Of course, rising profits allowed management to return capital to shareholders. Over the past decade, 3M's annual dividend per share has increased from $2.54 to $5.96.MMM PE Ratio (Forward) data by YChartsFortunately for investors, 3M stock is trading at a relative discount. Measuring by its forward price-to-earnings ratio of 12.46, 3M stock is selling at a valuation investors don't often see. Admittedly, the outcome of the litigation is a justifiable reason for the stock's decreased valuation, but the market may be overreacting to the news. This provides an excellent opportunity for long-term investors to capitalize on the lower price to add this dividend stock to their portfolios.CarParts.com: An under-the-radar e-commerce disruptorJeremy Bowman (CarParts.com): CarParts.com's revenue soared during the early stages of the pandemic, as the company was at the crossroads of two powerful pandemic tailwinds: e-commerce and auto parts. Consumers looked to online retail as they avoided shopping in stores, and auto parts sales also jumped as consumers took advantage of the extra time on their hands to fix up their vehicles. As a result, CarParts.com, the online auto parts retailer formerly known as U.S. Auto Parts, saw revenue growth nearly double in the fourth quarter of 2020 before decelerating as demand and the pandemic disruption normalized.Even as pandemic concerns ease, CarParts.com continues to grow its top line by double-digit percentages, taking market share in the industry, and it's improving its margins on the bottom line as well. In its third-quarter earnings report, revenue rose 16% year over year to $164.8 million, and gross profit increased 19% to $56.1 million. Its adjusted EBITDA also nearly tripled to $6.3 million.CarParts.com grew its business by adding new warehouses around the country so it can serve most of its customers with two-day delivery. It's also innovating with a new Do-It-For-Me service where the company is partnering with mechanics around the country who will seamlessly service customers who bring in CarParts.com parts, allowing them to save money as CarParts.com private-labels most of its merchandise, allowing it to undercut competitors on price.Additionally, the company should benefit from the current economic environment, as high interest rates are making new cars more expensive, encouraging car owners to repair their current vehicles rather than replace them. The auto parts sector also tends to do well in recessionary climates.Finally, the stock trades at a price-to-sales ratio of 0.6 and just 13 times adjusted EBITDA, making it cheap for a stock with its growth potential.If the company can continue growing the top and bottom lines, CarParts.com should be a winner from here.","news_type":1,"symbols_score_info":{"MMM":0.9,"PRTS":0.9}},"isVote":1,"tweetType":1,"viewCount":557,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9954802819,"gmtCreate":1676186751631,"gmtModify":1676186756155,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Amazing&nbsp;","listText":"Amazing&nbsp;","text":"Amazing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9954802819","repostId":"2310356099","repostType":4,"repost":{"id":"2310356099","kind":"highlight","pubTimestamp":1676179451,"share":"https://ttm.financial/m/news/2310356099?lang=en_US&edition=fundamental","pubTime":"2023-02-12 13:24","market":"us","language":"en","title":"The Smartest Investors Are Buying These 3 Beaten-Down Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2310356099","media":"Motley Fool","summary":"These stocks have all declined over the last year, but they are looking like good values now.","content":"<div>\n<p>Probably the most outstanding single quality that smart investors share is patience. The best-known smart investor of them all, Warren Buffett, famously doesn't try to time the market. Instead, his ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/11/the-smartest-investors-are-buying-these-3-beaten-d/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Smartest Investors Are Buying These 3 Beaten-Down Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Smartest Investors Are Buying These 3 Beaten-Down Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-12 13:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/02/11/the-smartest-investors-are-buying-these-3-beaten-d/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Probably the most outstanding single quality that smart investors share is patience. The best-known smart investor of them all, Warren Buffett, famously doesn't try to time the market. Instead, his ...</p>\n\n<a href=\"https://www.fool.com/investing/2023/02/11/the-smartest-investors-are-buying-these-3-beaten-d/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4211":"区域性银行","GOOGL":"谷歌A","AAPL":"苹果","UPS":"联合包裹"},"source_url":"https://www.fool.com/investing/2023/02/11/the-smartest-investors-are-buying-these-3-beaten-d/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2310356099","content_text":"Probably the most outstanding single quality that smart investors share is patience. The best-known smart investor of them all, Warren Buffett, famously doesn't try to time the market. Instead, his core strategy is to buy quality stocks at reasonable valuations -- and his holdings include positions in the first two companies discussed here.In the case of each of these three stocks, the buy thesis now pretty much requires investors to overlook their near-term negatives in favor of their long-term positives. Apple , UPS , and Alphabet all face earnings headwinds in 2023, but they will likely emerge stronger from any recession that coult potentially kick off this year. Here's why.1. Apple is improving its earnings qualityA combination of supply chain disruptions, a weakening environment for consumer discretionary spending, and adverse foreign currency exchange movements hit Apple in calendar 2022, and some of those issues are likely to extend well into 2023. That said, Apple's dominant position in the U.S. smartphone market and its opportunity to grow sales and market share worldwide as the number of smartphone users increases haven't gone away. Moreover, the underlying growth of its higher-margin services business is improving the quality of its earnings.While product revenue fell 8% year over year in its recently reported first quarter of fiscal 2023, its services revenue rose 6.4%. It would have increased by closer to 13% without the negative impact of foreign currency exchange rates. The growth of Apple's services revenue (which comes with a gross margin of nearly 71% compared to around 36% for its products segment) is improving Apple's long-term margin profile. Moreover, services now provide about 20% of Apple's total revenue (based on its fiscal 2022 results).Finally, as CFO Luca Maestri noted during the fiscal Q1 2023 earnings call, \"our installed base of active devices grew double digits and achieved all-time records in each geographic segment and in each major product category.\" That's likely to improve Apple's potential to grow its service revenue.2. United Parcel Service is focusing on more-profitable deliveriesAnother example of a company that is facing near-term headwinds but also significantly improving its business is UPS. The company's revenue declined 2.7% in the fourth quarter of 2022, and CFO Brian Newman said he expects that in 2023, average daily volume in its U.S. domestic segment will be \"down slightly,\" and average daily volume and revenue in its international segment will decline by low single-digit percentages.Still, note that Newman also said U.S. domestic segment revenue would increase by a low single-digit percentage despite that declining volume. That projection speaks to the underlying operational improvements UPS has been making. In a nutshell, management's transformational strategy to grow revenue from targeted end markets such as small and medium-sized businesses (SMBs) and the healthcare industry is working.Meanwhile, the company's emphasis on focusing on more-profitable deliveries -- which also entails reducing its lower-margin deliveries for Amazon.com -- means continuing \"a mutually agreed path to glide that business down in 2023,\" according to Newman.As such, UPS should continue to improve its underlying profitability even if a recession in 2023 leads to a revenue decline.Management's guidance for $8 billion in free cash flow (FCF) in 2023 would put UPS on a price-to-forward-FCF ratio of almost 21. That's a reasonable multiple if the company's earnings hit a trough this year and recover in the coming years, driven by underlying growth in SMBs, healthcare, and more-profitable e-commerce deliveries.3. Alphabet's wins will come from the cloudThe case for buying Alphabet is relatively simple. Solid but slowing growth in its Google services (Search, YouTube ads, and Google Network) will be balanced by the ongoing growth of Google Cloud as it marches toward profitability -- a business in which Alphabet has \"really been investing ahead of our revenues,\" CFO Ruth Porat said on its recent Q4 earnings call.The Google Cloud strategy makes perfect sense considering the potential for long-term cash generation from recurring revenue from customers that are likely to stay with Google Cloud on a multiyear basis.As for Google's other services, if there's a recession, that will hurt advertising revenue across the board, and the headline figure of a 2% decline in search revenue in the fourth quarter doesn't look good. Still, in that quarter, Alphabet's earnings were also pressured by adverse foreign exchange movements. Excluding the impact of those currency exchange headwinds, search revenues \"delivered moderate underlying growth in Q4,\" according to Porat. Moreover, Google's overall revenue growth of just 1% was 7% in constant currency.All told, Alphabet can look ahead to a year of solid but unspectacular growth. At the same time, Google Cloud is moving toward profitability, and Wall Street expects an incredible $70 billion in FCF, putting it on a forward-price-to-FCF multiple of 19. That's a good multiple for a company with Alphabet's long-term growth prospects.","news_type":1,"symbols_score_info":{"GOOGL":0.9,"UPS":0.9,"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":422,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9954063393,"gmtCreate":1675847651112,"gmtModify":1675847654627,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Better to 2050!","listText":"Better to 2050!","text":"Better to 2050!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9954063393","repostId":"2309700103","repostType":4,"isVote":1,"tweetType":1,"viewCount":474,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955523197,"gmtCreate":1675579935620,"gmtModify":1676539008401,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955523197","repostId":"2308684441","repostType":4,"repost":{"id":"2308684441","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1675558051,"share":"https://ttm.financial/m/news/2308684441?lang=en_US&edition=fundamental","pubTime":"2023-02-05 08:47","market":"us","language":"en","title":"The Stock-Market Rally Survived a Confusing Week. Here's What Comes Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2308684441","media":"Dow Jones","summary":"A key point of conflict requires resolutionInvestors can be excused for feeling a sense of confusion","content":"<html><head></head><body><p>A key point of conflict requires resolution</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3d84acd0fff9a6d03a294f0091d5a09d\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Investors can be excused for feeling a sense of confusion. GETTY IMAGES/ISTOCKPHOTO</span></p><p>Despite a Friday stumble, stocks ended a turbulent week with another round of solid gains, keeping 2023&#39;s young but robust stock-market rally very much alive.</p><p>But a cloud of confusion also sets over the market, and it will eventually need to be resolved, strategists said.</p><p>Stocks rose early in the week as traders continued to bet that the Federal Reserve won&#39;t follow through on its forecast to push the federal funds rate to a peak above 5% and hold it there, instead looking for cuts by year-end. Fed chief Jerome Powell pushed back against that expectation again on Wednesday, but a nuanced answer to a question about loosening financial conditions and an acknowledgment that the &#34;disinflationary process&#34; had begun convinced traders they remained right about the rate path.</p><p>On Friday, however, a blowout January jobs report, with the U.S. economy adding 517,000 jobs and the unemployment rate dropping to 3.4%, its lowest level since 1969, appeared to affirm Powell&#39;s position.</p><p>Stocks took a hit, even if they finished off session lows, with the Nasdaq Composite  booking a fifth straight weekly gain and the S&amp;P 500  achieving back-to-back weekly wins. The Dow Jones Industrial Average  suffered a 0.2% weekly fall.</p><p>&#34;It kind of leaves you shaking your head right now, doesn&#39;t it?&#34; asked Jim Baird, chief investment officer at Plante Moran Financial Advisors, in a phone interview.</p><p>At some point in the coming months there will need to be &#34;a reconciliation between what the markets think the Fed will do and what Powell says the Fed will do,&#34; Baird said.</p><p>The rally could continue for now, Baird said, but he argued it would be wise in the long run to take the Fed at face value. &#34;I think the overall tone of risk taking in the market right now is a little bit too optimistic.&#34;</p><p>Money-market traders did react to Friday&#39;s data. Fed funds futures on Friday afternoon reflected a 99.6% probability that the Fed would raise the target rate by 25 basis points to a range of 4.75% to 5% at the conclusion of its next policy meeting, on March 22, up from an 82.7% probability on Thursday, according to the CME FedWatch tool.</p><p>For the Fed&#39;s May meeting, the market reflected a 61.3% chance of another quarter-point rise to 5% to 5.25%, the level the Fed has signaled is its expected high-water-mark rate. On Thursday, it saw just a 30% chance of a quarter-point rise in May. But markets still look for a cut by year-end.</p><p>Of course, one month&#39;s data do not represent the end of the argument. But unless January&#39;s labor-market strength turns out to be a blip, the hawks on the Fed are likely to dig in and keep rates higher for longer, said Yung-Yu Ma, chief investment strategist at BMO Wealth Management, in a phone interview.</p><p>For markets, the lack of a resolution to the long-simmering disconnect with the Fed could lead to a period of consolidation after an admittedly impressive start to 2023, he said.</p><p>Indeed, the momentum behind the market&#39;s rally could be set to continue. It&#39;s been led by tech and other growth stocks that were hammered in last year&#39;s market rout. Market watchers detect a sense of &#34;FOMO,&#34; or fear of missing out, is driving what some have termed a tech-stock &#34;meltup.&#34;</p><p>&#34;The impressive equity rally to start the year has caught cautious institutional investors, hedge funds, and strategists off guard. While overbought conditions are obvious, the near-universal level of skepticism among institutions provides a contrarian degree of support for continued strength,&#34; said Mark Hackett, chief of investment research at Nationwide, in a Friday note.</p><p>And then there&#39;s earnings season, which has so far seen results from around half of the S&amp;P 500.</p><p>Companies through Friday had reported lower earnings for the fourth quarter relative to the end of the previous week and relative to the end of the quarter.</p><p>The blended earnings decline (a combination of actual results for companies that have reported and estimated results for companies that have yet to report) for the fourth quarter was 5.3% through Friday, compared with an earnings decline of 5.1% last week and an earnings decline of 3.3% at the end of the fourth quarter, according to FactSet. If earnings come out negative for the quarter, it would be the first year-over-year decline since the third quarter of 2020.</p><p>When it comes to earnings, &#34;there&#39;s definitely been a mood of forgiveness in the market,&#34; said BMO&#39;s Ma.</p><p>&#34;I think the market just didn&#39;t want to see a disastrous earnings season,&#34; he said, noting expectations remain for weak earnings in the current quarter and next, with bulls looking into the second half of this year and even into 2024 to get on a better footing.</p><p>For the market, the main driver will remain data on inflation and wage growth, Ma said.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Stock-Market Rally Survived a Confusing Week. Here's What Comes Next</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Stock-Market Rally Survived a Confusing Week. Here's What Comes Next\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2023-02-05 08:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>A key point of conflict requires resolution</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3d84acd0fff9a6d03a294f0091d5a09d\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Investors can be excused for feeling a sense of confusion. GETTY IMAGES/ISTOCKPHOTO</span></p><p>Despite a Friday stumble, stocks ended a turbulent week with another round of solid gains, keeping 2023&#39;s young but robust stock-market rally very much alive.</p><p>But a cloud of confusion also sets over the market, and it will eventually need to be resolved, strategists said.</p><p>Stocks rose early in the week as traders continued to bet that the Federal Reserve won&#39;t follow through on its forecast to push the federal funds rate to a peak above 5% and hold it there, instead looking for cuts by year-end. Fed chief Jerome Powell pushed back against that expectation again on Wednesday, but a nuanced answer to a question about loosening financial conditions and an acknowledgment that the &#34;disinflationary process&#34; had begun convinced traders they remained right about the rate path.</p><p>On Friday, however, a blowout January jobs report, with the U.S. economy adding 517,000 jobs and the unemployment rate dropping to 3.4%, its lowest level since 1969, appeared to affirm Powell&#39;s position.</p><p>Stocks took a hit, even if they finished off session lows, with the Nasdaq Composite  booking a fifth straight weekly gain and the S&amp;P 500  achieving back-to-back weekly wins. The Dow Jones Industrial Average  suffered a 0.2% weekly fall.</p><p>&#34;It kind of leaves you shaking your head right now, doesn&#39;t it?&#34; asked Jim Baird, chief investment officer at Plante Moran Financial Advisors, in a phone interview.</p><p>At some point in the coming months there will need to be &#34;a reconciliation between what the markets think the Fed will do and what Powell says the Fed will do,&#34; Baird said.</p><p>The rally could continue for now, Baird said, but he argued it would be wise in the long run to take the Fed at face value. &#34;I think the overall tone of risk taking in the market right now is a little bit too optimistic.&#34;</p><p>Money-market traders did react to Friday&#39;s data. Fed funds futures on Friday afternoon reflected a 99.6% probability that the Fed would raise the target rate by 25 basis points to a range of 4.75% to 5% at the conclusion of its next policy meeting, on March 22, up from an 82.7% probability on Thursday, according to the CME FedWatch tool.</p><p>For the Fed&#39;s May meeting, the market reflected a 61.3% chance of another quarter-point rise to 5% to 5.25%, the level the Fed has signaled is its expected high-water-mark rate. On Thursday, it saw just a 30% chance of a quarter-point rise in May. But markets still look for a cut by year-end.</p><p>Of course, one month&#39;s data do not represent the end of the argument. But unless January&#39;s labor-market strength turns out to be a blip, the hawks on the Fed are likely to dig in and keep rates higher for longer, said Yung-Yu Ma, chief investment strategist at BMO Wealth Management, in a phone interview.</p><p>For markets, the lack of a resolution to the long-simmering disconnect with the Fed could lead to a period of consolidation after an admittedly impressive start to 2023, he said.</p><p>Indeed, the momentum behind the market&#39;s rally could be set to continue. It&#39;s been led by tech and other growth stocks that were hammered in last year&#39;s market rout. Market watchers detect a sense of &#34;FOMO,&#34; or fear of missing out, is driving what some have termed a tech-stock &#34;meltup.&#34;</p><p>&#34;The impressive equity rally to start the year has caught cautious institutional investors, hedge funds, and strategists off guard. While overbought conditions are obvious, the near-universal level of skepticism among institutions provides a contrarian degree of support for continued strength,&#34; said Mark Hackett, chief of investment research at Nationwide, in a Friday note.</p><p>And then there&#39;s earnings season, which has so far seen results from around half of the S&amp;P 500.</p><p>Companies through Friday had reported lower earnings for the fourth quarter relative to the end of the previous week and relative to the end of the quarter.</p><p>The blended earnings decline (a combination of actual results for companies that have reported and estimated results for companies that have yet to report) for the fourth quarter was 5.3% through Friday, compared with an earnings decline of 5.1% last week and an earnings decline of 3.3% at the end of the fourth quarter, according to FactSet. If earnings come out negative for the quarter, it would be the first year-over-year decline since the third quarter of 2020.</p><p>When it comes to earnings, &#34;there&#39;s definitely been a mood of forgiveness in the market,&#34; said BMO&#39;s Ma.</p><p>&#34;I think the market just didn&#39;t want to see a disastrous earnings season,&#34; he said, noting expectations remain for weak earnings in the current quarter and next, with bulls looking into the second half of this year and even into 2024 to get on a better footing.</p><p>For the market, the main driver will remain data on inflation and wage growth, Ma said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2308684441","content_text":"A key point of conflict requires resolutionInvestors can be excused for feeling a sense of confusion. GETTY IMAGES/ISTOCKPHOTODespite a Friday stumble, stocks ended a turbulent week with another round of solid gains, keeping 2023's young but robust stock-market rally very much alive.But a cloud of confusion also sets over the market, and it will eventually need to be resolved, strategists said.Stocks rose early in the week as traders continued to bet that the Federal Reserve won't follow through on its forecast to push the federal funds rate to a peak above 5% and hold it there, instead looking for cuts by year-end. Fed chief Jerome Powell pushed back against that expectation again on Wednesday, but a nuanced answer to a question about loosening financial conditions and an acknowledgment that the \"disinflationary process\" had begun convinced traders they remained right about the rate path.On Friday, however, a blowout January jobs report, with the U.S. economy adding 517,000 jobs and the unemployment rate dropping to 3.4%, its lowest level since 1969, appeared to affirm Powell's position.Stocks took a hit, even if they finished off session lows, with the Nasdaq Composite  booking a fifth straight weekly gain and the S&P 500  achieving back-to-back weekly wins. The Dow Jones Industrial Average  suffered a 0.2% weekly fall.\"It kind of leaves you shaking your head right now, doesn't it?\" asked Jim Baird, chief investment officer at Plante Moran Financial Advisors, in a phone interview.At some point in the coming months there will need to be \"a reconciliation between what the markets think the Fed will do and what Powell says the Fed will do,\" Baird said.The rally could continue for now, Baird said, but he argued it would be wise in the long run to take the Fed at face value. \"I think the overall tone of risk taking in the market right now is a little bit too optimistic.\"Money-market traders did react to Friday's data. Fed funds futures on Friday afternoon reflected a 99.6% probability that the Fed would raise the target rate by 25 basis points to a range of 4.75% to 5% at the conclusion of its next policy meeting, on March 22, up from an 82.7% probability on Thursday, according to the CME FedWatch tool.For the Fed's May meeting, the market reflected a 61.3% chance of another quarter-point rise to 5% to 5.25%, the level the Fed has signaled is its expected high-water-mark rate. On Thursday, it saw just a 30% chance of a quarter-point rise in May. But markets still look for a cut by year-end.Of course, one month's data do not represent the end of the argument. But unless January's labor-market strength turns out to be a blip, the hawks on the Fed are likely to dig in and keep rates higher for longer, said Yung-Yu Ma, chief investment strategist at BMO Wealth Management, in a phone interview.For markets, the lack of a resolution to the long-simmering disconnect with the Fed could lead to a period of consolidation after an admittedly impressive start to 2023, he said.Indeed, the momentum behind the market's rally could be set to continue. It's been led by tech and other growth stocks that were hammered in last year's market rout. Market watchers detect a sense of \"FOMO,\" or fear of missing out, is driving what some have termed a tech-stock \"meltup.\"\"The impressive equity rally to start the year has caught cautious institutional investors, hedge funds, and strategists off guard. While overbought conditions are obvious, the near-universal level of skepticism among institutions provides a contrarian degree of support for continued strength,\" said Mark Hackett, chief of investment research at Nationwide, in a Friday note.And then there's earnings season, which has so far seen results from around half of the S&P 500.Companies through Friday had reported lower earnings for the fourth quarter relative to the end of the previous week and relative to the end of the quarter.The blended earnings decline (a combination of actual results for companies that have reported and estimated results for companies that have yet to report) for the fourth quarter was 5.3% through Friday, compared with an earnings decline of 5.1% last week and an earnings decline of 3.3% at the end of the fourth quarter, according to FactSet. If earnings come out negative for the quarter, it would be the first year-over-year decline since the third quarter of 2020.When it comes to earnings, \"there's definitely been a mood of forgiveness in the market,\" said BMO's Ma.\"I think the market just didn't want to see a disastrous earnings season,\" he said, noting expectations remain for weak earnings in the current quarter and next, with bulls looking into the second half of this year and even into 2024 to get on a better footing.For the market, the main driver will remain data on inflation and wage growth, Ma said.","news_type":1,"symbols_score_info":{".IXIC":0.9,".SPX":0.9,".DJI":0.9}},"isVote":1,"tweetType":1,"viewCount":733,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9957020600,"gmtCreate":1676790720400,"gmtModify":1676790724600,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9957020600","repostId":"1100725481","repostType":4,"repost":{"id":"1100725481","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1676779312,"share":"https://ttm.financial/m/news/1100725481?lang=en_US&edition=fundamental","pubTime":"2023-02-19 12:01","market":"us","language":"en","title":"Reminder: U.S. Market Will Be Closed for Washington's Birthday on Monday, Feb. 20, 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=1100725481","media":"Tiger Newspress","summary":"Washington's Birthday (Presidents Day) is around the corner. The U.S. market will be closed on Monda","content":"<html><head></head><body><p>Washington&#39;s Birthday (Presidents Day) is around the corner. The U.S. market will be closed on Monday, February 20, 2023. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.</p><p><b>About Presidents&#39; Day</b></p><p><b>Presidents&#39; Day</b>, also called <b>Washington&#39;s Birthday</b> at the federal governmental level, is a holiday in the United States celebrated on the third Monday of February to honor all people who served as presidents of the United States and, since 1879, has been the federal holiday honoring George Washington, who led the Continental Army to victory in the American Revolutionary War, presided at the Constitutional Convention of 1787, and was the first U.S. president.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9f9465ca4610b5c38f13638edda32b36\" tg-width=\"1024\" tg-height=\"576\" referrerpolicy=\"no-referrer\"/><span>George Washington with Flag</span></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reminder: U.S. Market Will Be Closed for Washington's Birthday on Monday, Feb. 20, 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReminder: U.S. Market Will Be Closed for Washington's Birthday on Monday, Feb. 20, 2023\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2023-02-19 12:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Washington&#39;s Birthday (Presidents Day) is around the corner. The U.S. market will be closed on Monday, February 20, 2023. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.</p><p><b>About Presidents&#39; Day</b></p><p><b>Presidents&#39; Day</b>, also called <b>Washington&#39;s Birthday</b> at the federal governmental level, is a holiday in the United States celebrated on the third Monday of February to honor all people who served as presidents of the United States and, since 1879, has been the federal holiday honoring George Washington, who led the Continental Army to victory in the American Revolutionary War, presided at the Constitutional Convention of 1787, and was the first U.S. president.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/9f9465ca4610b5c38f13638edda32b36\" tg-width=\"1024\" tg-height=\"576\" referrerpolicy=\"no-referrer\"/><span>George Washington with Flag</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100725481","content_text":"Washington's Birthday (Presidents Day) is around the corner. The U.S. market will be closed on Monday, February 20, 2023. Please take note of the trading arrangements during the holiday period and make the necessary preparations in advance.About Presidents' DayPresidents' Day, also called Washington's Birthday at the federal governmental level, is a holiday in the United States celebrated on the third Monday of February to honor all people who served as presidents of the United States and, since 1879, has been the federal holiday honoring George Washington, who led the Continental Army to victory in the American Revolutionary War, presided at the Constitutional Convention of 1787, and was the first U.S. president.George Washington with Flag","news_type":1,"symbols_score_info":{".DJI":0.9,".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}